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The improvement of lowered conditions of 
vitality brought on by disease or poisoning must 
have been a problem engaging the serious attention 
of people practising the healing art from the 
earliest days of human civilisation. This led 
to the use of various agencies, supposed to possess 
reviving powers, some of which survived through 
long periods of usage. Therapeutics in early days 
was purely empirical. Even after considerable 
advances in the knowledge of the pathology of 
these lowered conditions of vitality, very little 
attention was paid to enquiring into the nature 
of the reviving power of these agencies(by which 
was perhaps meant the improvement of some symptoms 
of lowered conditions). In many cases the improve- 
ment was due to the strong local irritant action of 
alcohol and other irritant constituents of the 
medicaments on the gastric mucosa, setting up a 
strong reflex stimulation of the respiratory and 
vasomotor centres and also perhaps partly to 
alcoholic contents thereof, acting as a diffusible 
stimulant/ 
-3- 
stimulant, and supplying ready nutrition to tissues. 
A few did act after absorption, and some of these 
caused improvements in lowered conditions by im- 
proving the circulation as cardio -vascular stimu- 
lants and a few others really acted through the 
nervous system, especially through the respiratory 
and other vital centres. 
Development of modern surgery brought in 
its train the use of anaesthetics which have their 
risks of extreme depression. This inspired an 
increased study of the nature of reviving drugs. 
With the rapid increase in the use of barbiturates 
as basal narcotics and anaesthetics, and also with 
the occurrence of poisoning, following their 
therapeutic administration, self- medication or 
suicidal attempts, the study of analeptic drugs 
has, in recent years, been engaging a good deal of 
attention of pharmacologists. Of the older drugs, 
picrotoxin and strychnine have been very thoroughly 
investigated, as also coramine and cardiazol amongst 
the newer synthetic drugs. Caffeine, cocaine, 
ephedrine, lobeline and a few others have also 
received some attention. 
The clinical use of some of these still 
persists in spite of their questionable status 
as/ 
-4- 
as judged by experimental evidences. 
No doubt a good number of therapeutic 
agents are of more or less symptomatic value in 
combating some of the effects of hypnotics and 
narcotics. But there is still a good deal of 
lack of unanimity regarding their usefulness in 
different stages of depression produced by the 
narcotics. The importance of the subject there- 
fore called for further study of the analeptics. 
Moreover, methods employed for the study of 
the problem were diverse in nature, and most of 
them had some unsatisfactory feature or other. For 
a truer evaluation and determination of the compara- 
tive worth of these drugs it was found necessary to 
evolve an efficient method free from those unsatis- 
factory features. Investigations undertaken for 
these purposes form the subject of this thesis. 
-5- 






Picrotoxin was first isolated in 1812 from 
Fish Berry - Cocculus Indicus - for a long time 
known to be used for poisoning fish. (The fish rose 
to the surface gasping, on account of their swim - 
bladder being distended with air. This rendered 
such fish poisonous). A similar substance also used 
to be added to beer to increase the bitter taste and 
this resulted in cases of poisoning. Picrotoxin 
is a non -alkaloidal non -nitrogenous neutral sub- 
stance. Its structural constitution is not yet 
definitely established, the chemical composition 
being represented by C30H34013. Cervello (1911) 
and Hormann (1913) found it to consist of two 
components, picrotinin C15H1806, the pharmacologi- 
cally active part, in feeble combination with a 
non -active component, picrotin, C15H1807. 
The first publication in analeptic literature 
comes from Tschudi (1847), who found picrotoxin 
antagonistic in action to morphine. Crichton 
Brown (1875) working on rabbits and guinea pigs, 
observed a physiological antagonism between 
picrotoxin/ 
-7- 
picrotoxin and chloral hydrate as chloral could 
control picrotoxin convulsion and picrotoxin raised 
the lethal dose of chloral from 0.5 gr. to 1 gr. 
per kilo. Amagat (1876) confirmed Brown's 
findings. (Perrier (1875) observed that in frogs 
and rabbits, toxiresins produced picrotoxin -like 
convulsions which could be controlled with chloral 
hydrate). Luchsinger (1678) reported that tetanic 
convulsions of picrotoxin persisted even after the 
destruction of the medulla. Gottlieb (182) 
obtained similar results and also reported that 
picrotoxin could interrupt the narcosis produced 
by paraldehyde and weaken that of the alcohol group 
of narcotics. Maxwell (106) reported that the 
direct application of picrotoxin to the cerebral 
motor cortex caused some stimulation, whereas 
similar application to the white matter produced 
none. 
Greenwald (100) and Morita (1pl5a) found 
that picrotoxin convulsions were not influenced by 
destruction of the hemispheres. Pollock and 
Holmes (11'15) observed that picrotoxin convulsions 
were not influenced by section below the optic 
thalamus. Janusche 0518) found that picrotoxin 
awakened/ 
-s- 
awakened guinea pigs from bromide sleep. Maloney 
and co- workers (1931, 1532) found that picrotoxin, 
even in small doses, given immediately before or 
after barbiturates, either prevented narcosis or 
shortened recovery period and saved the life of 
the animals which had received more than the usual 
fatal dose. They further found that the lowered 
body temperature caused by barbiturate depression 
was quickly brought back to normal by picrotoxin 
which also caused a prolonged rise of arterial 
pressure and fall of venous pressure and stimulated 
the respiratory mechanism. Swanson (1932) reported 
detoxication of picrotoxin, strychnine and cocaine 
by amytal. Gower and Erve (1933) reported that 
picrotoxin saved the life of dogs after one and a 
half lethal doses of barbital sodium. Barlow 
(1935) studied the shortening of the period of 
recovery from barbiturate hypnosis produced by 
different analeptics and also observed the effects 
on respiration, circulation and reflex excitability 
and judging by the degree of improvement in all 
these, estimated the relative efficiency and degree 
of usefulness to be in the order of picrotoxin, 
metrazol, ephedrine, coramine, strychnine and 
caffeine/ 
C 
caffeine. Koppanyi et al. (1936) found that 4 
I.L.D. h of barbital were counteracted by picrotoxin 
and that 70 M.L.D. of picrotoxin could be counter- 
acted by barbital. Kranz, Car and Beck (137) 
found that picrotoxin antagonised the depression 
of oxygen consumption produced by nembutal. 
Marshall, ?"alzl and LeLiessurier (1 37) observed 
that in barbiturate narcosis picrotoxin stimulated 
the depressed respiration by antagonising the 
depressants, whereas in normal animals, no stim- 
ulation of respiration occurred except after con- 
vulsive doses. Kohn (1938) determined the median 
lethal dose of picrotoxin for rabbits to be between 
1.2 and 1.3 mg. per kilo. and found that the H.L.D. 
rose to 7.5 mg. after nembutal. Repeating sub- 
lethal doses of picrotoxin for several days, he 
found no evidence of tolerance for the drug. 
Strychnine, C21H22N202. 
Strychnine was isolated in 1818 by 
Pelletier and Caventou. Arzt Dresbach (1850) 
reported that he observed some degree of antagonism 
between strychnine and chloroform. Liebreich 
(1870) noted that chloral could not prevent symptoms 
of and death from strychnine. Arnould (1670) and 
Ore/ 
-10- 
Ore (1872) could not get any beneficial effect 
from strychnine in chloral poisoning. Rajewasky 
(1872) reported to have succeeded in antagonising 
strychnine with chloral, provided the dose of 
strychnine was not too large. Hager and Etein_on 
(1875) reported strychnine to be ineffective 
against chloral poisoning. Husemann(1879) tried 
chloral against strychnine, brucine and physostig- 
mine and reported that chloral modified the excite- 
ment of these drugs by depression of the cord but 
the reverse was not true as the spinal excitants 
could not neutralise the coma of narcotics pro- 
duced by the action on higher centres. Cushny 
(1913) found that in animals, therapeutics' doses 
of strychnine increased the rate of respiration. 
Lovenhart (1918) reported that strychnine produced 
improvement in depression of respiration caused 
by cerebral compression. Hanzlik (1923) found 
that strychnine caused acceleration of respiration 
when excitability was partly depressed, especially 
in anaesthesia and morphine poisoning. Dragstead 
and Lang (1928), and Dawson and Taft (1931) 
reported experimental proof of efficiency of 
barbiturates/ 
barbiturates in strychnine poisoning. Maloney 
et al. (1931) reported antidotal value of 
strychnine against barbiturates to be quite low. 
Haggard and Greenberg (1932) reported the antagon- 
ism between strychnine and pentobarbital. Barlow 
(1932) stated that strychnine and pentobarbital 
were mutually antagonistic within limits, but 
strychnine in large doses further depressed 
respiratory mechanism already rendered hypoactive 
by the hypnotic. Chauchard (1934) demonstrated 
that strychnine augmented chronaxae diminished by 
barbiturates. Maloney (1935) found that in cases 
of severe depression of respiration by barbiturates, 
strychnine and cocaine hastened respiratory failure. 
Barlow (1935) placed strychnine between picrotoxin 
and metrazol as a resuscitation agent in order of 
effectiveness in pentobarbital poisoning, but 
considering the margin of safety and improvement 
of respiration and circulation,placed strychnine 






CH3 - N - C = 0 
I I /CiH3 
0 =C C- N 1.3.7-trimethyl-2.6.dihydroxy 
I f 
;H purine. 
CH3 - N - C - N 
Caffeine was isolated in 1820 by Runge, 
Pelletier and Caventou. Bennett (1874) used 
caffeine against morphine poisoning. Binz (1878) 
found that caffeine definitely antagonised alcohol 
in dogs and that caffeine increased the respiratory 
rate in anaesthetised animals. Heinz (1890) re- 
ported that he obtained an increase in depth of 
respiration after caffeine but Cushny (1913) found 
that in decerebrate animals, caffeine only increased 
the rate of respiration and depth either remained 
unchanged or even became shallower. Airilla (1913) 
observed that caffeine was only of temporary value 
against chloral. Vogtlin and Wiggers (1918) found 
that caffeine slightly stimulated respiration and 
circulation in depressant poisoning but the effects 
soon became additive to the depressants. Hanzlik 
(1923) found that the respiration of unanaesthetised 
animals was depressed by 10 mg. /kg. doses of 
caffeine 
-13- 
caffeine. Duke (1923) reported that in narcotic 
poisoning, caffeine restored consciousness even 
when other analeptics failed, but the effect was 
merely temporary. jagner (1931) reported that 
small doses of caffeine diminished the depth of 
light hypnosis of chloral but large doses exagger- 
ated the depressant effects of chloral. Barlow 
(1935) found that caffeine in good doses only 
moderately improved the respiration after hypnotics, 
and excessive doses, after the initial stimulation, 
had a secondary depressant action which was additive 
to that of the hypnotics. Maloney (1935) reported 
that sub - lethal doses of caffeine after single sub- 
lethal barbiturate dosage in rats, caused transient 
arousal followed by relapse, and beyond a stage 
added to the depression of the hypnotic and killed 
by depression and not by convulsion and declared 











CH - CH2 
Cocaine was isolated in 1860 by Niemann. 
Mosso (1887) reported diminution of depth of 
chloral narcosis by cocaine. Feinberg and Blumen- 
thal (1887) reported absence of cocaine convulsion 
after ablation of the cerebrum in dogs. Morita 
(1915) found in rabbits, deprived of cerebral hemis- 
pheres, absence of clonic but onset of tonic convul- 
sion and increase in resistance to toxic doses. 
Airila (1913) found dogs awakened from deep chloral 
(1932) 
sleep after cocaine. Sollmann states that stage of 
stimulation may be short or absent, succeeded with 
larger doses by depression of co- ordinating centres 
and that seat of convulsive action is descending, 
different centres being affected in succession. 
both (1917) found that small doses increased 
respiration while large doses were depressant, 
killing by respiratory paralysis. Tatum, Atkinson 
and Collins (1925) found that barbital controlled 
cocaine convulsion, but the reverse was found not 
true/ 
-15- 
true. Swanson (1932) stated that cocaine antidoted 
lethal doses of barbiturates, but Maloney (1933) 
reported that cocaine hastened respiratory failure. 
Barlow (1935) declared the practical usefulness 
of cocaine and nicotine as analeptics to be 
questionable. 
Lobeline, C1BH24N0. 
Lobelia is a native plant of North America, 
where it has been for centuries used as a remedy 
for bronchitis and asthma. It was introduced into 
medicine about the beginning of the nineteenth 
century by Samuel Thompson who used it against 
morphine to stimulate respiration. It contains a 
liquid alkaloid C16H24NQ. Small doses of it were 
stated by Sollmann to lower CO2 threshold producing 
marked stimulation of respiration. He further 
stated it to be effective in overcoming respiratory 
depression of morphine in the rabbit, and less 
effective in chloral depression, but the response 
was uncertain. Eckstein (1921) considered it 
clinically valuable in pneumonia and asphyxia. 
Norris and Weiss (1927) stated it to be ineffective 
and even dangerous. Wieland and Mayer (1927) 
experimentally produced lowered CO2 threshold and 
stimulation/ 
-1E- 
stimulation of respiration by lobeline. This was 
less constant or absent in morphinised animals and 
effective doses produced toxic TaampttatiszE4. effects 
and secondary depression. 
Ephedrine, C10H15N0. 
The Chinese plant "Ma Huang" was known and 
used there as a therapeutic agent over 2000 years. 
Its active alkaloid ephedrine is pharmacologically 
0?I NH.CH3 
C - C - C - CH3 
I 1 
H H 
similar to adrenaline and is more stable but many 
times weaker so that proportionately bigger doses 
produce slower and more prolonged effects. Airilla 
(1913) reported that ephedrine antagonised effects 
of chloral hydrate. Morita (1915b) confirmed this. 
Kreitmair (1927) found that ephedrine antagonised 
morphine and morphine -scopolamine depression. 
Rajewsky and Bourne (1931) reported that ephedrine 
diminished or interrupted avertin narcosis. Barlow 
(1935) stated that from degree of symptomatic 
improvement, ephedrine appeared very effective 
against chloral because of circulatory stimulation, 
but/ 
-17- 
but large doses tended to give added depression, 
and that medullary and vasopressor effects of 
ephedrine markedly accentuated the stimulant effects 
of picrotoxin, metrazol and coramine. 
Benzedrine. 
Barger and Dale (1910) first described 
benzedrine as ß- phenyl- isopropylamine. It is a 






















Tainter (1933) and Alles (1933) reported 
on its central stimulating effects. Prinzmetal 
and Bl000mberg (1935) stated that benzedrine 
possessed more stimulating effect on the central 
nervous system than ephedrine and was able to 
awaken animals from experimental barbiturate 
narcosis and also showed an insomnia -producing 
effect on human cases. They also reported 
successful cases of narcolepsy treated with 10 -40 
mg. Mayerson, Loman and Dameshek (1936) reported 
of its producing gradual rise in blood pressure 
sustained for a very long time. Ehrich and 
Krumbahr (1937) found after repeated doses in rats 
very slight tolerance. Reifenstein and Davidoff 
(1938) reported using 10 mg. of benzedrine sulphate 
every 15 minutes in a case of amytal sodium poisoning 
(0.5 g.) till narcosis disappeared and blood 
pressure rose. 
Camphor and Allied Drugs. 
Camphor, C10H160, was long ago known to be a 
convulsion -producing drug. Alberton (1882) 
located the seat of convulsions of camphor to be 
in the cerebral hemispheres as removal of these 
with section below optic thalami diminished or 
abolished/ 
-19- 
abolished them. This was confirmed by Morita 
(1915). Gottlieb (1892) reported that camphor 
antagonised or interrupted paraldehyde hypnosis 
áollmann stated that effects of non -convulsive 
doses of camphor on respiration were slightly 
inconstant and frequently negative. Wieland(1915) 
reported lowering of CO2 threshold. Hanzlik (1923) 
reported fair increase of respiration after hypo - 
deiinic injection of camphorated oil into animals. 
Camphor was also reputed to be a circulatory 
stimulant although various workers reported contra- 
dictory results as to its effectiveness and limi- 
tations. Very poor solubility of camphor in water 
and very slow absorption from oily solution 
injected (allowing camphor to be converted into 
non -active campho- glycuronic acid and preventing 
effective concentration in blood) together with 
continental faith in efficacy of camphor, led to 
introduction of a series of camphor substitutes, 
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., amphor HexatIone 
This is also not very soluble in water but is 
soluble in a 20% solution of sodium salicylate. 
Part of the effect obtained from this was 
undoubtedly due to the solvent and hexatone failed 
fulfil the that created it. 
Coramine. C 0 N C21-45 \eZ 
t1/4 
This is a thick yellowish liquid, freely soluble 
in water and other organic solvents and fairly 
stable. `It is not irritant locally or subcutane- 
ously and absorbed pretty rapidly from oral, 
subcutaneous or intramuscular injection. 
The first published reference to this drug 
came in 1922 from Lagier who discussed its 
pharmacological properties as a circulatory 
stimulant under the name "nicotinic acid- diethyl- 
amide / 
-21- 
amide" from its structural resemblance with 
nicotinic acid C00 14 
N 
Wieland and Mayer (1922) reported it to be a 
stimulant to the respiratory centre. Thannhauser 
and Fritzel (1924) used the trade name "coramine" 
for a 25ó aqueous solution of the drug and stated 
this to be of definite value in collapse and cardiac 
decompensation. Faust (1925) described it as 
pyridine -3- carboxy- diethylamide and reported it to 
be a cardiac, respiratory and vasomotor stimulant. 
Since the introduction of this drug, the experi- 
mental and clinical aspects of its activity have 
provoked the appearance of an enormous amount of 
literature (over 1400 publications) out of which 
a few important ones are being referred to. 
Uhlmann (1924 ), Asher (1928), Schübel and 
Gehlen (1928) confirmed the previous reports of 
Wieland and Mayer about its having a good 
respiratory stimulant action. Helaers (1924) 
also supported this and declared it to be very 
prompt and reliable. Earlier reports of Lagier 
about its circulatory stimulant action were con- 
firmed by Asher (1925), Burgi and Gordonoff and 
many other workers. Leyko (1930), employing 
Starling/ 
-22- 
Starling heart -lung preparation reported increase 
in coronary flow which was later confirmed by 
Mezey (1935) and by Greene (1936). Zurz and 
Trimonti (1931) employing denervated carotid 
sinus, showed that coramine lost its respiratory 
stimulant action after morphine depression, 
whereas cardiazol gave prolonged stimulation, 
and concluded that coramine stimulated respiratory 
centre indirectly through carotid sinus in normal 
therapeutic doses and directly only after large 
doses. Schoen (1926) reported light narcosis 
of paraldehyde (1 g. /kg.) and of chloral (0.6 g. /kg.) 
controlled by 50 mg. /kg. of coramine in 10 minutes, 
but large or repeated small doses could not control 
deep narcosis. Mbrl (1931), Killian and Uhlman 
(1931) and several others report favourably in 
tribrom- methanol depression, but Jager (1932) and 
Lendle (1936) found narcosis prolonged, and Albus 
(1932) reported that awakening doses of coramine 
were highly toxic and killed. Tartler (1929) 
found only transient awakening after 200 mg. /kg. 
of medinal in rats amd the smallest effective 
dose caused appearance of cramp, and larger doses 
while/ 
-23- 
while producing clonic spasms drove animals into 
fuller narcosis. Maloney, Fitch and Tatum (1931) 
found general unsuitability of coramine in barbi- 
turate poisoning. Moritch (1932) found that after 
veronal, luminal and somnifene, the sleep deepened 
and the toxicity increased by coramine. Kohn and 
Jacobi (1935) and Zipf (1936) also reported fuller 
narcosis with the drug and also stated that it 
hastened death of experimental animals. Lendle 
(1936) found pernocton narcosis often lengthened by 
coramine. Zipf and co- workers (1937) observed 
prolonging of narcosis from pernocton, rectidon and 
eunarcon. Schwab and Jung (1936) found in guinea 
pigs under evipan narcosis, recovery greatly pro- 
longed (from 2 or 3 hours to about 20 hours). Zipf 
(1937) reported similar findings in rats. Thitehead 
and Lraper (1939) used a closed soda -lime absorption 
system for inhalation of volatile anaesthetics and 
determined the minimal dose of ether and chloroform 
required for the respiratory arrest of individual 
dogs (which were later on resuscitated by oxygen 
and artificial respiration). They found the intra- 
venous injection of 37.5 mg. /kg. of coramine did not 
minimal 
cause any change in the,(amount required for the 
respiratory/ 
-24- 
respiratory arrest in either case and in the case 
of chloroform doubled the rate of mortality. 
Cardiazol. 
Cardiazol is a white crystalline solid 
having a sweetish aromatic odour, readily soluble 
in water and saline, making a neutral solution 
which can be sterilised by boiling. It is non- 
irritant to skin and mucous surfaces and is very 
readily absorbed even after oral administration 
and there is little difference in reaction time 
following intravenous injection as compared to 
hypodermic route. 
In 1924 Schmidt discovered the method of 
catalytic splitting of hydrazoic acid HN3 into 
HN and N2. Later he succeeded in introducing 
tetrazole radicle = N - N 
I 
N - N 
(obtained by oxidation of two HN3 groups) into 
nitrogen -free carbonyl compounds ( of the type 
R 





compounds of the type C = N - N 
N - N 
The next step was the breaking into the cyclo- 
hexanone ring for the introduction into it of a 
H2 .ct1 V 
C 
\\\c2 
Z C NZ 
nitrogen atom of the tetrazole radicle, thus 
yielding pentamethylene tetrazole, which was given 
the trade name cardiazol (or metrazol in U.S.A.). 
Cf-12. 




The first report of the investigation of 
this drug came from Krehl (1925) and then from 
Schmidt, Hildebrandt and Krehl (1925). Later 
Hildebrandt made more through study of the drug 
and reported it to be a stimulant to heart and 
central nervous system, especially the respiratory 
centre. The respiratory stimulant action was later 
confirmed/ 
-26- 
confirmed by various workers. Schoen (1926) 
studied the seat of convulsion produced in rabbits by 
extirpating cerebral hemispheres which produced no 
change, and on further removal of thalami, basal 
ganglia, and anterior quadrate bodies, could still 
produce typical convulsions although with three 
times more dosage, thus leading to the conclusion 
that principal seat of action of cardiazol was 
in the subcortical centres. Camp (1928) could 
not find any increase of spinal irritability in 
rats and rabbits after cardiazol. Contrary 
results were reported by Koll (1937) who explained 
Camp's negative results as due to using too small 
doses. Barker and Levine (192e) reported not 
finding any tonic effect of cardiazol on cardio- 
respiratory mechanisms of the cat in normal or 
depressed condition. Watt (1929) found it 
depressing mammalian heart and showing no pressor 
action in deep narcosis. Johnston (1929) found 
clinical proof of usefulness of cardiazol in 
circulatory collapse and myocardial insufficiency. 
Leyko (1930) using Starling heart -lung preparation, 
found/ 
-27- 
found after cardiazol no effect on tone of heart 
or coronary circulation. Orestano (1929) 
attributed respiratory improvement to cardiac action 
whereas Grenels (1931) held circulatory improvement 
as secondary to respiration and dependant upon it. 
Buding (1930) classed cardiazol as a picrotoxin- 
like drug; Schwab and Guizetti (1931) placed 
cardiazol between digitalis and camphor as circul- 
atory stimulant. Schoen (1926) reported awakening 
by intravenous cardiazol in urethane, alcohol and 
paraldehyde narcosis. Tartler (1929) and I.:ehl 
(1930) found medinal sleep of rats broken by 
cardiazol. Medinal- cardiazol antagonism was also 
reported by Maloney (1935) and Kohn and Jacobi 
(1936). Jager (1932) reported awakening from 
avertin sleep by cardiazol. Kohn and Jacobi (1935) 
Lendle (1936), Albus (1936) and Zipf and Mertins 
(1937) reported similar results. Barlow (1935) 
Gros (1936, Zipf et al. (1937) found cardiazol 
antagonising chloral hydrate and Schoen (1926), 
Gros: (1936), Hoffmann (1936), paraldehyde. Schwab 
and Jung (1936) found evipan narcosis shortened to 
half by cardiazol and convulsive and lethal doses 
of/ 
-28- 
of cardiazol increased by 2 to 3 times after 
evipan. Steininger and Gaubatz (1935) reported 
cardiazol better than coramine in morphine poisoning. 
(1935) 
Barlow placed cardiazol as next to picrotoxin as 
a reviving drug and Koppanyi et al. (1936) described 
it as equal to or better than picrotoxin as 
awakening agent. Thiel (1937) found in morphine 
plus pernocton narcosis, in dogs, cardiazol - 
sympathol combination better than coramine or 
lobeline; whereas in CO poisoning neither 
cardiazol nor coramine had any effect. Rice and 
Isenberger (1937) had no improvement in amytal 
narcosis by intracisternal injection of cardiazol 
or coramine whereas picrotoxin reduced the duration 
of respiratory paralysis. Werner (1938) in a 
comparative study of picrotoxin, cardiazol and 
coramine, placed cardiazol as next to picrotoxin 
in order of efficiency. 
B. / 
In 1879 Murrel reported (in The Practitioner) 
having used picrotoxin clinically in 0.5 to 1 mg. 
doses. Further reports appeared in the British 
Medical Journal of 1830. Howard (1890) reported . 
that he used with advantage 0.6 mg. for children 
and 1.2 mg. for adults. Strychnine has also been 
used by various clinicians in earlier days. With 
rapid increase in accidental and suicidal cases of 
narcotic poisoning and consequent extensive experi- 
mental investigations, therapeutic uses of analeptics 
against narcotics and vice versa have received a 
fresh impetus in recent times. Thus picrotoxin has 
received considerable attention in America, whereas 
the French school has taken to strychnine, and in 
Germany, camphor derivatives particularly coramine 
and cardiazol had extensive clinical application. 
Reports about the last group are numerous and 
varied; various people reported about them as 
having yielded excellent results as respiratory and 
even circulatory stimulants, and some others gave 
less favourable reports and a few reported of having 
disappointing and even contrary results. For 
example Killian (1931), Mori (1931), Domanig (1931), 
Fischman/ 
-30- 
Fischmann (1932), Kennedy (1932), Epecht (1932) 
reported having very encouraging results from 
coramine in avertin depression. Glaesser(1933) 
reported success in luminal poisoning, Altmann 
(1932) in barbital poisoning (270 g.), Ludwig and 
Hortnagel (1932) in opium poisoning and ' ?good (1933) 
in surgical shock. Jager (1933) on the other hand, 
reported failure of coramine to influence 
respiratory depression. 
Report of clinical use of strychnine as 
analeptic in recent times comes from Ide (1932) 
who stated having good results in veronal poisoning 
in man. Luschke (1933) reported similar clinical 
experience and recommended big and frequently 
repeated doses. Kouman (1934) reported cure of a 
case of strychnine poisoning by intravenous 
pernocton and Hamori (1936) of a case of pernocton 
poisoning by strychnine. D'0elsnitz and co- 
workers (1933) reported two severe cases of 
barbiturate coma treated with strychnine, one of 
which survived and the other died in spite of 
strychnine. Thereon these authors stated that 
individual sensitivity differed and that some cases 
led/ 
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led to more quick fixing of barbiturate in the 
bulbar centres than others. Flandin and Bernard 
case of 
(1 933) reported death of a,(barbiturate poisoning 
after 67 hours of strychnine treatment. Von 
Paraf, Delay and Macrez (1533),and Ramon and Delay 
(1933) similarly reported death in spite of 
strychnine. Olmer and Audier (1934) state that 
the result depends on the intensity of barbiturate 
poisoning and recommend in every case trial with 
strychnine. 
Burstein and Rovenstein (1937) reported on 
clinical use of picrotoxin, ietrazol (cardiazol) 
and coramine, recommending 3 mg. of picrotoxin i.v., 
repeated in 5 minutes and more if necessary till 
symptomatic effect produced and then intramuscularly; 
metrazol 1.5 to 2 c.c. intravenously repeated in 
5 minutes and then intramuscularly, and coramine 
25 c.c. or repeated doses of 5 c.c. till 25 c.c. 
given. They found 3 to 6 mg. of picrotoxin giving 
best response (improvement of rhythmicity, depth 
and rate of respiration and frequently stimulation 
of circulation) and causing less prominent cerebral 
symptoms than metrazol in morphine depression. 
Intravenous metrazol caused immediate improvement 
in/ 
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in respiration and circulation, but the effect 
was transitory. Coramine effect was equally 
transitory and less marked. In ether, paraldehyde 
and cyclopropane depression metrazol effect was 
best and coramine least. Only in tribrom- methanol 
depression coramine was most effective. In 
depression of spinal anaesthesia, fall of blood 
pressure and respiratory minute volume were not 
appreciably relieved by any, whereas circulatory 
depression of surgical shock was not materially 
benefited by any one alone. 
Bleckwenn, Iasten and Tatum (1937) reported 
having found picrotoxin as best of all in 
barbiturate poisoning. They used 1 in 1000 sol- 
ution, i c.c. per minute, i.e. 1 mg. per minute 
intravenously. 
Rovenstein (1938) reported four severe cases 
of barbiturate poisoning treated by picrotoxin 
of which only the last one could not be saved. The 
first (114 g. amytal sodium) received 3 mg. doses 
of picrotoxin till 129 mg. given, the second (90 
g. nembutal) had 3 mg. doses till 48 mg. The 
third (75 g. of sodium luminal ) had 128 mg. and 
the fourth (500 g. of veronal) had 23mg. in the 
beginning/ 
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beginning (at 1 mg. per minute), then 24 mg., 
30 mg., 21 mg. and 23 at intervals of one to two 
hours, along with intravenous saline, and then 
20 mg. per hour intramuscularly for 20 hours, and 
finally 10 mg. per hour intramuscularly. The case 
appeared practically recovered and treatment was 
stopped but suddenly symptoms relapsed ending in 
death. From his clinical experience, this author 
advises that besides persistent treatment with 
picrotoxin, one must attend to other therapeutic 
measures like maintenance of body temperature, 
frequent gastric lavage, catheterisation, frequent 
clearing of trachea and change of posture, besides 
diuretics, oxygen and even blood transfusion. 
-34- 
III. PRODUCTION AND MAINTENANCE OF A STEADY 
STATE OF RESPIRATORY DEPRESSION BY CON- 
TINUOUS INFUSION OF SODIUM EVIPAN. 
-35- 
The chief purpose for which analeptics are 
used clinically is the stimulation of the respir- 
atory centre, and the most promising method for 
investigating the action of analeptics is to 
measure their effect on the respiratory centre 
after this has been depressed. The chief diffi- 
culty is to obtain a constant degree of depression 
of the respiratory centre. One method of pro- 
ducing this effect is to administer some drug, 
such as phenobarbitone, which has a very prolonged 
action. The defence mechanisms of the body 
against drugs are however so complex and efficient, 
that it is difficult to obtain a prolonged and 
uniform depression by such means. 
An alternative method is to give a continuous 
intravenous infusion of a drug which is rapidly 
destroyed by the body. Sodium evipan is a 
familiar example of such a drug, and experiments 
were therefore made to determine whether it was 
possible to produce a steady degree of respiratory 
depression by means of continuous intravenous 
infusion/ 
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infusion of evipan. 
Method. 
The respiration was measured by means 
of a plethysmograph which was a modification of 
that used by Cushny (1913) for investigating 
the pharmacology of the respiratory centre. 
Fig. 1 gives a diagrammatic sketch of the 
apparatus and arrangements. A lead sheet, 16" x 
12" x s " was bent along its shorter axis into 
the shape of a dome. The animal (rabbit) was 
placed on the table on its back. The dome, when 
placed over the animal, remained quite clear of 
its body. An airtight bag, made out of very 
thin rubber cloth,was interposed between the 
dome and the animal's body. The bag was broad 
enough to cover the animal's body from side to 
side and extended over the whole of the animal's 
chest and abdomen. When properly inflated, the 
bag occupied the whole space between the dome and 
the animal's body. 
Fig. 1/ 
Pig. 1. Diagrammatic sketch of the float recorder and 
15e - respiratory plethysmograph. (Detailed description 
in the text). 
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experiment. For convenience of comparison, 
the figure for normal respiration was expressed 
as 100 and all other figures were converted into 
percentages of the normal respiration. `.`then these 
percentage figures were plotted against time, a 
curve was obtained that graphically represented 
the respiratory activity of the animal for 
the whole period of the experiment. 
Experimental Precautions. Certain precautions 
had to be taken to avoid possible sources of 
error in this method. 
(1) The animal had to be handled as gently as 
possible and care was taken to avoid any sound or 
other source of nervous excitement of the rabbit - 
a naturally timid animal. Even when this was 
done, it was often found necessary to wait for 
ten to twenty minutes or even more until the 
animal's respiration became regular and normal. 
The amount of respiratory activity in the normal 
condition was, of course, a figure of great 
importance in the construction of the respiratory 
curve of the whole experiment. 
(2) / 
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(2) Another important factor was the maintenance 
of the normal body temperature, as variations 
in temperature were noticed to cause changes in 
the respiratory activity of the rabbit. A rise 
of temperature increased respiratory activity 
and respiratory depression resulted from a fall 
of temperature below normal, to a certain extent 
beyond which shivering ensued. 
Arrangements were therefore made to maintain 
steady body temperature. The top of the experi- 
mental table was made of a sheet of copper. 
Electric bulbs fitted below this sheet heated the 
sheet nearly uniformly. The animal was placed 
on this, with a pad of cotton beneath its body to 
avoid direct heat of the sheet. Frequent reading 
of a thermometer placed inside the rectum, was the 
guide to the putting off or putting on of the 
electric bulbs, so as to maintain a rectal 
temperature between 37.5 °C. and 38 °C. 
(3). The maintenance of a uniform rate of flow 
of the fluid infused was very important as the 
whole success of the experiment depended on this. 
The/ 
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The usual drop method from a burette was used at 
first, a constant pressure being provided by a 
Mariotte tube arrangement. As the size of a drop 
varied slightly with the rapidity of falling of a 
drop as well as with the size of the dropping point, 
the counting of the drops alone could not be relied 
on for a uniform rate of flow, but in addition to 
this, the burette reading was frequently watched 
in order to ensure a uniform rate of flow and 
adjustments of clips and taps were corrected if 
necessary. For the sake of accuracy, the quantity 
infused could not be reduced too much, and the 
minimum quantity of fluid that had to be used per 
minute with accuracy insured, caused free diuresis, 
washed out the drugs and thus lowered their concen- 
tration. All these difficulties were eliminated 
by the use of an apparatus which mechanically 
injected 0.1 c.c. per minute at a uniform rate. 
The perfusion apparatus (Fig. 2) consisted 
essentially of a wheel, a long square rod and a 
10 c.c. record syringe. 
Fig. 2/ 
Fig. 2. Diagrammatic sketch of the continuous 
diffusion apparatus. (Detailed description in the 
text). 
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The wheel was placed between two supporting pillars 
and was rotated by means of belting from an electric 
motor, with the intervention of a system of reducing 
gears to obtain a very slow speed. The wheel had 
screw threads cut in a circular hole through its 
centre, and corresponding threads were cut at the 
four angles of the square rod, which passed through 
the circular hole of the wheel and also through two 
square holes of the two supporting pillars. A knob 
at the end of the rod touched the back of the 
handle of the piston of the springe, the barrel 
of which was clamped to a stand. The rotation 
of the wheel tended to rotate the square rod, but 
the square holes of the supporting pillars pre- 
vented this and a forward movement of the rod was 
caused, equal to the distance between two screw - 
threads, for each complete rotation of the wheel. 
This resulted in the piston of the syringe being 
pushed forward to the same extent. The combination 
of gears used permitted the injection of 1 c.c. 
in 10 minutes, i.e. 0.1 c.c. in one minute. By 
altering the combinations of gears and using 
syringes of different bores, the rate of injection 
could/ 
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could be reduced or increased ten times. 
Limitations. 
The method of producing a depression of the 
respiratory centre by evipan and its antagonism 
by analeptics yields satisfactory results. The 
quantitative accuracy of the method, however, is 
affected by some limitations. 
(1) Individual variation. x good deal of 
individual variation is noticed in the & ount of 
effect produced by the same dose (per kg.) of 
evipan on different animals. The accuracy of 
calculations about the rate of excretion of evipan 
on data obtained by this method is therefore sub- 
ject to this factor. 
(2) Recovery process. This is complicated by the 
fact that when the respiratory centre is depressed, 
CO2 accumulates, and as the depressant drug is 
removed and depression relieved, the CO2 stimulates 
the respiratory centre. The recovery rate is 
therefore quicker than would be produced by the 
rate of elimination of evipan. In many cases, 
the respiratory activity rises above normal during 
recovery/ 
recovery. Thus this factor affects the figures 
about the rate of elimination of evipan calcul- 
ated on the time of recovery. 
If these limitations are recognised, the 
method is very useful in studying the problems 
connected with narcotic analeptic antagonism. 
Results. 
Preliminary experiments showed that the 
most satisfactory method for producing a steady 
depression of respiration was to tranquillise the 
rabbit with an initial dose of 15 to 20 mg. per kg. 
of evipan and then to continue with continuous 
infusion and see whether further depression or 
recovery occurred. 
Fig. 3 shows that respiration and blood 
pressure of a rabbit were both depressed after 
1 mg. /kg. of evipan followed by 0.6 mg. /kg. per 
minute continuous infusion. But whereas the 
blood pressure soon returned almost to its former 
level, the respiratory activity continued to remain 
depressed (at 48 per cent, below normal, calculated 
by the above described method). 
Fig. 3/ 
4 6 
Fig. 3. Upper curve: respiration; lower curve: 
blood pressure. Time 5 secs. The rabbit received 
10 mg. /kg. of evipan followed by 0.6 mg. /kg. /min. 
continually infused. It can be seen that blood 
pressure recovered after some time but the res- 
piration continued to remain depressed. 
In order to estimate the probable 
concentration of evipan which corresponds to a 
given degree of respiratory depression, it was 
necessary to construct a curve relating evipan 
dosage and corresponding depression. 
A dose of sodium evipan rapidly injected 
into the ear vein of the rabbit causes an 
immediate depression of the respiratory activity. 
The animal, however, quickly begins to recover 
and soon returns to normal. (In many cases, the 
respiratory activity rises above normal during 
recovery on account of 002 accumulation, as 
mentioned before). The respiratory curve, after 
acute evipan, shows an almost vertical fall and a 
rapid rise back to the normal level. 
Unfortunately there is a wide individual 
variation in respect of sensitivity to evipan. 
The author has collected results from his own 
work and has been kindly supplied with additional 
data by Dr Raventos. These figures are shown 
in Table I and Fig. 4. 
Table I / 
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Table I. 
Respiratory depression after acute evipan. 
No. of experi- 





No. of experi- 






concentration of evipan necessary to produce any 
given depression can be read off. 
Mg . /Kg . 



















curve obtained in Fig. 4 the 
The results obtained by continuous infusion 
of evipan are summarised in Table II and also re- 
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Fig. 4. Curve showing the extent of respiratory 
depression produced by acute intravenous injection 
of evipan. 
+ values obtained by author given in Table I. 
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steady the Figs. 5, 
state 6 and 7. 
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Nearly at Curve (1), 
25 Fig.5. 
20 52 0.5 do. at 34 Curve (2),do. 
20 ¡ 55 0.5 do. " 36 " (3),do. 
20 ! 62 0.5 do. " 39 " (4),do. 
20 55 0.5 do. " 41 " (5),do. 
20 57 0.5 do. " 45 " (6),do. 
20 60 0.6 do. " 48 " (7),do. 




" 58 Curve (1), 
Fig.6 
20 62 0.8 do. 
" 62 " (2),do. 
20 68 1.0 do. " 63 " (3),do. 
20 67 1.0 do. " 65 " (4),do. 





15 32 1.5 do. " (2),do. 
15/ 
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15 35 1.5 do. " (4),do. 
10 25 1.5 do. " (5),do. 
15 42 1.5 do. " (6),do. 
15 50 1.2 do. " (7),do. 






Fig. 5. Superimposed respiratory curves of the 
experiments summarised in top part of Table II. 
Initial dose was 20 mg. /kg. in all cases. Contin- 
uous dose was 0.35 mg. /kg. /min. for curve 1 (broken 
line - - -) and 0.6 mg. /kg. /min. for curve 7 (dotted 




Fig. 6. Superimposed curves of experiments summarised 
in the middle part of Table I.I. Initial dose 
20 mg. /kg. for all cases. Continuous dose 0.8 mg. /kg./ 
min. for curves 1 and 2 (broken lines - - -) and 















































































































































































































































































































The average results can be described as 
follows: 
(a) Intravenous infusion followed by recovery (cf. 
An injection of 20 mg. /kg. of evipan produced 
an immediate depression of between 50 to 65 per 
cent. A continuous intravenous infusion of 0.5 
mg. /kg. per minute, following the above initial 
dose, resulted in slow recovery. The depression 
of respiration returned to about 40 per cent. in 
about 30 to 60 minutes and then remained steady. 
Presumably, at this point, the removal and intro- 
duction of the drug were equal. The amount of 
respiratory depression corresponds to an evipan 
blood concentration of 13 mg. /kg. (cf. Fig. 4). 
and since the condition is steady with the intro- 
duction of 0.5 mg. /kg. /min., therefore the proportion 
destroyed per minute must be 0.5/13 = 1/26 of the 
amount present. 
(b) Steady state. (cf. Fig. 6). 
With an initial dose of 20 mg. /kg. and a 
constant intravenous infusion of 0.8 to 1.0 mg. /kg. 
the respiratory depression was constant at about 
60/ 
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60 per cent. which corresponds to an evipan con- 
centration of 25 mg. /kg. (cf. Fig. 4). This 
suggests that the introduction and removal were 
balanced from the onset. Hence the destruction 
must have been about 0.8 to 1.0/25 = about 1/25 
of the evipan present. 
(c) Further depression (cf. Fig. 7). 
After an initial dose of 15 mg./kg. followed 
by a continuous infusion of 1.5 mg. /kg. per minute 
respiratory depression increased fairly rapidly. 
In one case (curve 2, rig. 7) respiratory arrest 
nearly occurred after 100 minutes, and in another 
(curve 4, Fib-. 7) after 200 minutes. The amount 
of evipan needed to produce rapid respiratory 
arrest is between 30 to 50 mg. /kg. It may there- 
fore be concluded that an infusion of 1.5 mg. /kg. 
per minute raised the blood evipan from 15 mg. /kg. 
to 40 mg. /kg. in about 100 minutes. If 1/25 of 
the evipan present were destroyed per minute, then 
the rate of destruction would balance an infusion 
of 1.5 mg. /kg., when the blood concentration was 
38 mg. /kg. Fig. 2 indicates that probably the 
constant maintenance of a blood concentration of 
38 mg. /kg. would produce a respiratory arrest. 
The/ 
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The following experiments were made to 
provide as conclusive a proof as possible of the 
nature of the clearance of sodium evipan. An 
experiment of the type shown in Table II was made 
on a rabbit. y large dose (50 mg. /kg.) of sodium 
evipan was injected cautiously so that respiratory 
depression just short of arrest was produced. This 
was followed by continuous infusion of 1 mg. /kg. 
minute of sodium evipan. With this treatment the 
animal recovered to a steady state of 30 per cent. 
depression. This effect can only be accounted for 
by the assumption that a fixed proportion of the 
drug present is cleared per minute. This conclusion 
was confirmed by making another experiment on the 
same rabbit (to eliminate individual variation) a 
few days later. In this case no initial dose of 
evipan was given, but only a continuous injection 
of 1 mg. /kg. /min. This caused a slow fall of 
respiratory activity to the same steady state that 
was finally reached in the previous experiment. 
Three pairs of such experiments were made with 
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Fig. 8. Broken line (- - -) = the respiratory 
curve of a rabbit that received 50 mg. /kg. of 
evipan slowly given i.v. followed by 1 mg. /kg. /min. 
continuous infusion. Continuous line ( ) 
curve of the same animal receiving 1 mg. /kg. /min. 
of evipan without any initial dose, 4 days later. 
Both attained steady course at nearly same level. 
-59- 
Since the continuous infusion was the same 
in both cases, the approximation to the same final 
steady state cannot be explained by removal of a 
constant quantity of the drug per minute, whereas 
this result is to be expected if a constant pro- 
portion of the drug present is removed per minute. 
In another experiment (of the type of the 
second part of the above pairs of experiments), a 
continuous injection of 1 mg. /kg. /min. without any 
initial dose, was maintained for 8 hours. The 
respiratory depression, after the slow fall in the 
beginning, assumed a steady state which was there- 
after maintained throughout the whole period of 
this lengthy experiment. (See Fig. 9) 
These experiments therefore provide fairly 
conclusive proof that the proportion and not the 
amount of drug removed per minute is constant. 
Discussion. 
(a) These experiments with prolonged perfusion 
demonstrate certain facts of interest. An acute 
injection of less than 50 mg. /kg. of sodium evipan 
is sufficient to arrest respiration in the rabbit. 
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Fig. 9. Portions of respiratory tracing of a rabbit that 
received a continuous infusion of 1 mg. /kg. /min. of evipan 
(without an initial dose) for 8 hours. Respiratory 
depression became steady in about an hour and continued 
so for 7 hours. 
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was infused for 180 minutes after an initial dose 
of 15 mg. /kg. Hence the rabbit received a total 
of 285 mg. /kg. of sodium evipan. This is nearly 
six times the acute lethal dose. It is improbable 
that such a quantity could be detoxicated by 
fixation by tissues such as subcutaneous fat. 
Hence such results provide fairly certain evidence 
of the breakdown of evipan. 
(b) There are two methods of breakdown of drugs. 
(i) In the case of alcohol (and of substrates 
destroyed by enzymes when the substrate is present 
in excess), a fixed amount is oxidised per minute 
and this amount is not affected by the concentration 
In these cases there can be only one rate of con- 
tinuous infusion which can produce equilibrium, 
namely, that which exactly equals the rate at 
which the body can destroy the drug. 
(ii) In the case of most drugs (and of sub- 
strates destroyed by enzymes when the substrate is 
not in excess), a fixed proportion of the drug 
present is broken down per minute (e.g. acetyl- 
choline, Clark and Raventos, 1938). With this 
mode/ 
mode of destruction, continuous infusion can produce 
equilibrium at different levels. 
The results described above which were 
observed with continuous infusion of evipan, can 
only be explained on the second hypothesis. If, 
for example, the body always removed 1.0 mg. /kg. 
per minute of evipan, then this would explain the 
steady depression produced by this dose, but with 
an initial dose of 20 mg./kg., an infusion of 0.5 
mg. /kg. per minute and a constant destruction of 
1.0 mg. /kg. per minute, almost complete recovery 
would occur in 40 minutes. Similarly with an 
initial dose of 15 mg. /kg., a constant infusion of 
1.5 mg. /kg. per minute and a destruction of 1.0 
mg. /kg. per minute, a lethal quantity (about 45 mg./ 
kg.) would accumulate in 60 minutes. 
On the other hand, the results can be 
interpreted satisfactorily on the hypothesis that a 
constant proportion is destroyed. Figs. 5 and 6 
show that equilibrium can be attained at more than 
one rate of continuous infusion. With a continuous 
infusion of 0.5 mg. /kg. per minute the level of 
depression is equal to that produced by about 13 
mg. /kg. 'gith a constant infusion of 1.0 mg. /kg. 
the/ 
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the level of depression is equal to that of 
20 -25 mg. /kg. Clark and Raventos (1938) cal- 
culated the cumulation produced by intermittent 
administration of drugs, when a constant fraction 
of the amount present is broken down per unit of 
time. These calculations apply approximately 
to continuous infusion and it may be assumed that 
if a drug is introduced at X units per minute and 
a constant fraction ( 1 /y) of the amount present 
is destroyed per minute, then the concentration (C) 
ultimately produced will be xy(C = xy). As 
0.5 and 1.0 mg. /kg. constantly infused produce 
steady depression of 40 per cent. and 60 -65 per 
cent respectively, Fig. 4 provides the following 
two equations: - 
13 = 0.5 y and 25 = 1.0 y 
This gives y = 25. 
If 1/25 of the amount present is destroyed 
per minute, then half destruction occurs in 19 
minutes. This result is in accordance with 
observations on the duration of action of evipan. 
Dr Raventos has kindly permitted me to 
quote the following figures for the relation 
between/ 
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between the dosage of evipan and the duration of 
depression of respiration. These were obtained 
with a single rabbit. The individual variation 
is so wide that it is difficult to compare results 
obtained with different animals. 
Table III. 
Dose of sodium 















These times can be interpreted on the 
assumption that the minimum effective dose is 
7 mg. /kg. and that half destruction occurs in 20 
minutes. 
According to the calculations made above, 
a continuous infusion of 1.5 mg. /kg. /min. of evipan 
would produce a concentration equal to 25 x 1.5 or 
38 mg. /kg. 
causes/ 
This is a dose which frequently, 
-64- 
causes respiratory arrest and hence the steady 
increase of respiratory depression obtained with 
this rate of infusion agrees with the hypothesis 
outlined above. 
(c) Continuous intravenous infusion of a drug with 
a mode of destruction like that of alcohol soon 
leads to cumulation of greater and greater amounts. 
But no cumulation occurs after equilibrium is 
established in the case of drugs whose definite 
fraction is destroyed per unit of time. The 
information that a definite fraction of evipan is 
destroyed per unit of time therefore is of 
practical importance in its use as an intravenous 
anaesthetic by constant infusion of a suitable 
dose, which can be continued for prolonged periods 
with the confidence that no further accumulation 




These experiments with evipan prove the 
following facts:- 
1. The method of estimating respiratory activity 
that has been described, provides a convenient 
quantitative measure. 
2. Continuous infusion of sodium evipan will 
produce a respiratory depression that remains con- 
stant in its intensity for hours. 
3. Steady respiratory depression at different 
levels can be produced by varying the rate of 
intravenous infusion of sodium evipan. 
4. The results can be interpreted on the assumption 
that a constant fraction of the evipan present in 
the body is destroyed per minute. The results 
indicate that about 1/25 of the evipan present is 
destroyed per minute. This equals half destruction 
in about 20 minutes. 
5. This information about the mode of destruction 
of/ 
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of evipan renders it suitable for use as an 
intravenous anaesthetic by continuous infusion 
method, with the confidence that the margin of 
safety will not be encroached upon beyond the 
equilibrium level. 
-67- 
IV. MEASUREMENT OF ANALEPTIC EFFICIENCY. 
-68- 
The problem of the analeptic activity of 
drugs has been approached by workers in different 
ways. In the first place some authors have 
studied hypnotic and analeptic activity on isolated 
organs and tissues. Jowell and Quastel (1937) 
studied the oxygen consumption of brain slices 
under varying conditions. Porter and Allamon 
(1936) avoided the use of whole animals as being 
"subject to vagaries of the intact nervous system 
and difficulty of finding reliable criteria for 
measuring depth of anaesthesia" and used spinal 
cats. With the help of special types of "liquid 
electrodes ", they studied the threshold of the 
flexian reflex and found an increase of the 
threshold under barbiturates and a lowering thereof 
after strychnine. The results of this interesting 
work, useful so far as the isolated spinal cord is 
concerned, cannot unfortunately be taken as a real 
standard of the analeptic efficiency of strychnine 
against the barbiturates in the intact cat. In 
fact, it is these "vagaries" that count in the 
matter of the analeptic activity and the true 
evidence of the analeptic activity has to be 
obtained from intact animals with no (or as little 
as/ 
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as possible) interference with their anatomical 
and physiological condition. Most workers have 
therefore employed intact animals. 
Nielson, Higgins and Spruth (1925), Eddy 
(1928) and Shonle, Keltch and Swanson (1930) have 
used the diminution in the depth of barbiturate 
depression (judged by subjective methods) produced 
by analeptics as the ratio of their efficiency. 
Personal errors in such subjective methods must 
necessarily be large enough to render the results 
inaccurate. 
Anderson, Chen and Leake (1930) used the 
diminution of basal metabolism as a measure of the 
degree of depression. Kranz, Car and Beck (1937) 
determined the oxygen consumption of white rats, 
in normal conditions, after nembutal, and after 
nembutal followed by picrotoxin, and showed from 
average figures that picrotoxin restored the 
oxygen consumption to normal when this had been 
depressed by nembutal. 
This method has the disadvantage that there 
is a good deal of variation in the individual 
response of different animals and there are drugs 
like adrenaline that increase the oxygen consumption 
of normal animals as well as narcotised ones without 
antagonising/ 
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antagonising the narcotics. 
Barlow (1930) determined the concentration 
of N20 necessary to produce anaesthesia in rats 
before and after analeptics. Apart from other 
considerations, the individual factor cannot be 
eliminated in this method. 
Attempt have for a long time been made to 
estimate the analeptic value of a drug by noting 
the maximum amount of a narcotic against which an 
analeptic can protect an animal. Brown as early 
as 1875 showed that picrotoxin could protect 
rabbits against 5 to 8 times the lethal dose of 
chloral hydrate. This method, although it gives 
valuable information about the efficiency of a 
potent analeptic, gives no definite idea as to how 
it behaves at different periods of its action. 
Similar remarks may be made about methods adopted 
by Maloney et al. (1931, 1933, 1935), Barlow (1955) 
and Koppanyi et al (1936) who noted the awakening 
from or shortening of drug -sleep or its prevention 
by different analeptics for estimating their 
relative efficiency. 
Attempts were also made to determine the 
corresponding/ 
-71- 
corresponding counterbalancing doses of hypnotics 
and analeptics by noting the increase in the 
minimum convulsive doses of analeptics caused by 
the previous administration of different doses of 
hypnotics. But the appearance of convulsions in a 
depressed animal is not always an indication of 
impending recovery, because in a deeply narcotised 
animal, convulsions may be produced by a stimulant 
drug without causing awakening, and some barbituric 
acid derivatives can produce hypnosis and convulsions 
at the same time. 
Barlow stressed the importance of judging 
the degree of the improvement that different 
analeptics could produce in the respiration, the 
circulation and the reflex excitability of animals 
in barbiturate narcosis, although he relied on 
a subjective observation of these, without adopting 
any objective method of recording them. 
Continental workers (Uhlmann (1924), Helaers 
(1929), Hildebrandt (1926, Rein (1933)' used records 
of the minute volume of respiration by tracheal 
intubation for demonstrating the analeptic 
efficiency of coramine and cardiazol. But the 
anaesthesia required for the operation of tracheotomy 
deprived/ 
deprived them of the figure for normal conditions 
for comparison, and the operation did not leave 
the animal quite intact. Long ago Cushny (1Çl3) 
discarded tracheal intubation for recording 
respiration volume as he observed that rabbits 
whose respiration was recorded by tracheal cannula, 
suffered from dyspnoea and further noted that the 
attachment of a Chauveau valve close to the trachea 
deepened respiratory movement. 
Larshall and co- workers (193 7) reported 
that they had some dogs trained to remain quiet 
on the experimental table with airtight masks 
fitted on to the face, and measured the inspiratory 
and expiratory volumes with Bohr gasometers. They 
attempted to revive the respiration by analeptics 
after causing respiratory failure by denervation 
of the carotid sinus or by oxygen administration in 
a deep condition of narcosis. (They held that this 
latter procedure diminished the CO2 concentration 
of the blood and deprived the carotid sinus and 
aortic receptors of the only source of stimulus 
necessary for the reflex stimulation of the 
respiratory centre). The limitations and compli- 
cations of this method weigh too much against 
any/ 
-73- 
any possible advantages it may possess. Smyth (1937) 
used a less complicated method for studying the 
effects of denervation of the carotid sinus on 
respiration. He enclosed the rabbit in an air- 
tight chamber and recorded amplitude of respiration 
by a float volume recorder connected with the 
chamber. A mask was fitted airtight over the 
animal's face. A tube passing airtight through 
the wall of the chamber established communication 
between the face -mask and outside and served as 
passage for breathing in and out of the mask. Apart 
from other difficulties from the position of the 
animal with the mask inside a small airtight 
chamber, the animal's body was not accessible for 
injection of drugs during the experiment without 
undoing the airtight arrangement. 
That depression of respiration was the 
deciding factor in extremely depressed conditions, 
brought on by narcotics, was demonstrated by the 
following experiment. A steady depression was 
produced in a rabbit by the continuous injection of 
0.E mg. /kg. /min. of evipan and its blood pressure and 
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Fig. 10. Respiration (upper curve) and blood 
pressure (lower curve) of a rabbit under continuous 
evipan anaesthesia with 0.8 mg. /kg. /min. following 
20 mg. /kg. initial dose. Rapid i.v. injection of 
another 20 mg. /kg. of evipan caused respiratory 
parally sis, but blood pressure after an initial fall, 
recovered. Animal saved by artificial respiration. 
-7 5- 
Another dose of 20 mg. /kg. of evipan rapidly 
injected intravenously produced such a depression 
of the respiratory centre that respiration stopped 
after a few respiratory movements, while the blood 
pressure, after an initial fall, almost recovered 
its previous level, and the animal was saved from 
immediate death by artificial respiration. 
It was found in the preliminary group of 
experiments that the maximum dose of continuous 
evipan that could be given to rabbits with safety 
was 1 mg. /kg. /min. Larger quantities produced a 
gradually increasing depression and caused death. 
Such lethal doses of continuous evipan were used 
in this group of experiments to determine the 
antagonising capacity of analeptics. By suitable 
adjustments, a dose of the analeptic could be found 
which prevented the downward slope of the curve 
(due to the lethal dose of evipan) and maintained it 
at a horizontal level during the period of continuous 
infusion of both the drugs (extending over 12 - 2 
hours). This dose of the analeptic therefore 
antagonised the dose of the evipan given by contin- 
uous infusion. The doses of picrotoxin required 
to/ 
-76- 
to antagonise different doses of evipan were 
determined in this manner and it vas found that 
the doses of evipan varied as the logarithms of 
the doses of picrotoxin. 
The action of analeptics on the rabbit's 
respiratory centre when this is depressed by con- 
tinuous infusion with sodium evipan, can be measured 
in various ways, as will be seen in the following 
description of the different methods employed in a 
study of the analeptics. 
I. The simplest method was to give a single intra- 
venous dose of an analeptic and measure the intensity 
and duration of its stimulant action on the respir- 
ation of a rabbit receiving a continuous infusion of 
evipan. The resulting increase in the respiratory 
activity could be read off from the respiratory 
curve prepared in the way described in a previous 
chapter. The intensity of action was indicated by 
the rise of the curve above the horizontal level of 
the curve maintained by evipan, and the duration, by 
the time taken by the curve to return to the hori- 
zontal level. Ficrotoxin, coramine, cardiazol, 
strychnine/ 
-77- 
strychnine and a number of new synthetic compounds 
were in this way investigated in order to determine 
the analeptic efficiency of each at different levels 
of depression. (The results of these studies will 
follow) . 
H. Comparison of different analeptics. 
This method afforded special facilities for 
comparing the analeptic efficiency of different 
drugs under almost identical conditions. The 
analeptics produced a transient action and hence 
when the infusion rate of evipan was kept constant, 
the respiration in course of time returned to the 
level of depression that had been present before 
the administration of the analeptics. Hence it 
was possible to administer different analeptics 
alternately to the same animal and thus compare 
their efficiency. In this manner errors due to 
individual variation could be eliminated. 
III. Continuous infusion of analeptics and of evipan 
simultaneously. 
(a) Single injections of an analeptic did not 
give any exact idea of the rate of elimination of 
the drug. In other experiments, therefore, 
analeptics/ 
-78- 
analeptics were given by slow continuous infusion, 
along with a dose of continuous evipan, which alone 
was sufficient to maintain a steady level of 
depression. Starting from a very small dose per 
minute, of the analeptic, and gradually increasing 
the dose in successive experiments, a point could 
be reached beyond which the respiratory curve did 
not maintain a steady level but showed a gradual 
sloping rise. Beyond this point the rate of 
destruction of the analeptic infused was greater 
than the rate of elimination and this provided an 
estimate of the rate of elimination of the drug 
at the level of the depression produced by the dose 
of continuous evipan administered simultaneously. 
In the case of some drugs (e.g. coramine) 
it was noticed that the gradual rise in the 
respiratory curve in experiments of this group could 
not be maintained long, but the curve gradually came 
down and dropped below the level of depression due 
to evipan alone, in spite of the continuous infusion 
of the analeptic, and on stopping the infusion of the 
analeptic, the respiratory curve returned to the 
level of evipan depression. This clearly indicated 
a secondary depressant effect of the analeptic - a 
feature/ 
-7ç 
feature that would not have been demonstrated 
otherwise. This method also led to the detection 
of the limitations of drugs like strychnine in the 
appearance of convulsions when given by a continuous 
infusion long before the depression of evipan was 
fully overcome. 
Summary. 
Quantitative estimates of the activity of 
analeptics were obtained from the increase in the 
respiratory activity of rabbits whose respiration 
was maintained in a steady state of depression by a 
continuous intravenous infusion of sodium evipan 
(0.8 mg. to 1.0 per kg. per minute following an 
initial dose of 20 mg. /kg.). 
The intensity of action of single doses of 
analeptics was indicated by the rise of the 
respiratory curve above the steady level maintained 
by evipan and the duration by the time taken by the 
curve to get back to the previous steady level. 
Different analeptics were compared under 
identical conditions, injecting them alternately. 
By simultaneously infusing both evipan and analeptics, 
quantitative estimations of the antagonism between 
the/ 
-80- 
the barbiturate and the analeptic were obtained. 
This procedure also elicited valuable information 
about the rate of detoxication of the analeptic 
and evidence of secondary depressant effects, if 
any, possessed by the analeptic. 
-81- 
V. ANTAGONISM OF EVIPAN BY PICROTOXIN. 
-82- 
The antagonism between barbiturates and picro- 
toxin has been studied by various authors, and the 
following quantitative estimates are of interest. 
Maloney and co- workers (1931) gave fixed doses 
of barbiturates to rabbits and followe6 this by 
varying doses of picrotoxin and thus determined the 
amount of picrotoxin which would cause survival.They 
obtained the following results. 
Table IV. 
Mg. 60- 80- 10 ̂- 125- 150- 175- 200 
Amytal 100 150 200 
Picro- 
toxin 3.6 4.1 20.7 
Ipral 150 175 200 
Piero- 
toxin 
5.7 9.0 14.5 
Nem- 
butai 
60 80 100 125 150 
Picro- 
toxin 2.2 2.5 4.4 12.3 32.2 
Pernoc- 
ton 100 125 150 200 
Picro- 




150 175 200 
Piero - 
toxin 4.3 7.3 13 
-83- 
Koppanyi et al. (1936) observed the 
awakening effects of picrotoxin in nembutal 




20 mg. 40 mg. 60 mg. 80 mg. 
4 mg. 8 mg. 16 mg. 32 mg. 
Fig. 11 shows the curves obtained by 
plotting the above figures. ln practically all 
these cases the curves are converted into straight 
lines if log. doses of picrotoxin are substituted 
for picrotoxin doses (Fig. 12). 

































































































































































































































































































































































These curves relating dosage of barbiturate 
with log. dosage of picrotoxin are all nearly 
parallel which is surprising, because the duration 
of action of phenobarbitone is so much greater 
than that of nembutal. The general relation can 
be stated that it is necessary to increase the 
picrotoxin dosage fourfold in order to antagonise 
an increment of 50 mg. /kg. of barbiturate. This 
relation explains why it is possible to antagonise 
such a wide range of picrotoxin dosage by barbi- 
turates,whilst only a comparatively narrow range 
of barbiturate dosage can be antagonised by 
picrotoxin. 
Experimental. 
Two types of experiments were carried out. 
(i) Continuous intravenous evipan was given at a 
rate which produced a steady respiratory depression. 
Single doses of picrotoxin were injected and the 
amplitude and duration of the respiratory stimulation 
were measured. 
The same method was employed to compare 




(ii) Measurements were made of the antagonism 
between a continuous infusion of evipan and a 
continuous infusion of picrotoxin. This method 
permitted the balancing of evipan and picrotoxin 
and it was possible to work up to doses of both 
drugs,either of which alone would have been fatal. 
(i) Antagonism of evipan by a single dose of laicro- 
toxin. 
Fig. 13 shows an example of this type of 
experiment. An initial dose of 20 mg. /kg. followed 
by a continuous infusion of 0.6 mg. /kg. sodium 
evipan produced a steady respiratory depression 
at 55 per cent. below normal. The injection of 
picrotoxin (0.3 mg. /kg.) produced a temporary 
stimulation of respiration which lasted 20 -30 
minutes. The temporary nature of the effect 
indicates that the picrotoxin is fairly rapidly 
detoxicated in the body. A dose of 0.2 mg. /kg. 
produced no certain stimulation of respiration. 
Fig. 13/ 
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Fib. 13. Respiratory curve of an experiment with 
two doses of picrotoxin each 0.3 mg. /kg. given to 
a rabbit receiving 0.6 mg. /kg. /min. of evipan 
following an initial dose of 20 mg. /kg. 
The result indicates therefore that the 
picrotoxin is reduced to 2/3 in 30 minutes. This 
corresponds to a destruction of about 1.6 per 
cent. per minute. 
A second dose of picrotoxin given about 
an hour after the first produced an identical 
response, a fact which supports the view that the 
picrotoxin is completely detoxicated in the body 
in a fairly short time. 
Picrotoxin was found to be an extremely 
powerful stimulant even when the respiratory centre 
was almost completely paralysed. This effect is 
shown in Fig. 14.(a) and (b). The animal almost 
stopped breathing and the continuous infusion of 
evipan was stopped. Two doses of coramine (10 mg. 
and 20 mg. /kg.) produced no benefit. But 0.3 mg. /kg. 
picrotoxin produced an improvement whilst 0.4 mg. /kg. 
picrotoxin given shortly afterwards restored the 
respiration nearly to normal. 
This instance shows the marked superiority 
of picrotoxin over other analeptics, a subject which 
will be discussed later. 
Fig. 14 / 
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Fig. 14(a). Respiratory curve of a case of severe 
respiratory depression after evipan. Corainine 30 
mg. /kg. failed to improve the condition. Picrotoxin 
0.3 mg. /kg. followed by 0.4 mg. /kg. restored the 
respiratory activity to nearly normal. 
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Fig. 14(b). Portions of tracing of the experiment 
represented by the curve in Fig. 14(a). 
611 
-92- 
In another case a rabbit had an initial 
dose of 10 mg. /kg. evipan followed by a continuous 
infusion of 1.5 mg. /kg. /min. The respiratory 
depression gradually increased till at the end of 
hours the respiration stopped completely. 
Evipan infusion was now stopped and a dose of 1.2 
mg. /kg. of picrotoxin given.Soon the animal restarted 
breathing at a slow rate, but the respiratory rate 
steadily increased till in 10 minutes it reached the 
normal level. (Fig. 15). 
Fig. 16(a) shows the manner in which the 
action of different analeptics can be compared 
quantitatively by successive injections into rabbits 
in which a steady depression of the respiratory 
centre is maintained by continuous infusion of 
evipan. The remarkable feature of this figure is 
the steady basic level of respiratory depression which 
was maintained for 5 hours. Portions of the actual 
tracing of this experiment are shown in Fig. 16(b). 
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(ii) The antagonism between continuous intravenous 
infusion of evipan and of picrotoxin. 
Fig. 17 shows an example of the results 
obtained by this method. A steady depression was 
produced by evipan. Partial recovery was produced 
by 0.3 mg. /kg. picrotoxin and this recovery was 
maintained at a nearly constant level by continuous 
intravenous infusion of 0.004 mg. picrotoxin per 
minute. This result indicates that with this 
rate of infusion, the rate of destruction of picro- 
toxin in the body, nearly balanced the rate of 
infusion. This indicates a destruction of 
0.004/0.3 or 1/75 per minute of the drug present. 
More striking results were obtained when 
infusions of evipan were given which would have 
caused respiratory arrest if not antagonised by 
picrotoxin. 
Fig. 17 / 




















































































































































































































































































































Fig. 18 shows an example of this type. 
In this case 0.7 mg. /kg. picrotoxin with a con- 
tinuous infusion of 0.008 mg. /kg. /min. produced 
a steady level of partial recovery. This 
indicates a destruction of 0.008/0.7 = 1/87 per 
minute of the drug present. 
Fig. 19 shows that after 0.9 mg. /kg. 
picrotoxin an infusion of 0.006 mg. /kg. /min. did 
not maintain the initial recovery. Hence the 
amount destroyed was more than 0.006/0.9 = 1/150 
per minute. 
Fig. 20 indicates a rate of destruction of 
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Fig. 19. An initial dose of 15 mg. /kg. of evipan 
followed by 1.5 mg. /kg. /min. of evipan was causing 
a rapidly increasing depression. 0.3 and 0.6 
(= 0.9) mg. /kg. of picrotoxin caused an increase of 
respiratory activity but 0.006 mg. /kg. /min. of 
picrotoxin could not keep it up. On stopping con- 
tinuous picrotoxin the depression increased so 
rapidly that the animal died in 10 minutes. 
s0; 
-101- 
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Fig. 20. 2 mg. /kg. /min. of evipan following an 
initial dose of 10 mg. /kg. was producing a rapidly 
increasing depression. 0.7 mg. of picrotoxin 
improved the condition and 0.015 mg. /kg. /min. of 
picrotoxin kept it up almost at a steady level. 
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Fi . 21. Depression was rapidly increasing under 
2.0 mt. kg. /min. following 10 mg. /kg. of evipan. A 
continuous infusion of picrotoxin at the rate of 0.01 
mg. /kg. /min. checked the progress of the depression 
but could not wholly control it. After a while 
picrotoxin was infused at the rate of 0.03 mg. /kg. /min.. 
This proved too strong for the evipan and caused a 
steady increase of the respiratory activity in spite 
of the evipan infusion. 
1r..+YJiI 
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Pig. 22. A depression was caused by a dose of 15 mg. /kg. 
of evipan. Then a continuous infusion of 2.5 mg. /kg. /min. 
of evipan was started and was soon followed by a con- 
tinuous infusion of 0.03 mg. /kg. /min. of picrotoxin. 
For one hour the depression was steady. Another dose 
of 15 mg. /kg. of evipan given at this point increased 
the depth of depression, while the simultaneous con- 
tinuous infusions of evipan and picrotoxin balancing 
each other kept the new depression level steady. After 
another 30 min. a further dose of 15 mg. /kg. of evipan 
given i.v. quickly produced serious depression and soon 
killed the animal. This last dose turned the scale in 
favour of too high concentration of evipan which was 




The results obtained by the author with 
continuous simultaneous infusion of picrotoxin and 





















0.6 0.004 2 Antagonised 0.6 E 0.004 P 
1.2 0.008 2 do. 1.2 E 0.008P 
1.5 0.006 Picrotoxin too 
little to anta- 
gonise. 0.01 
mg. would pro- 
bably antagon- 
ise 
1.5 E 0.01 P 
2.0 0.015 1 Antagonised 2.0 E 0.015P 
2.5 0.03 lL do. 2.5 E 0.03 P 
-105- 
On plotting the figures of the last column 
the curve shown in Fig. 23(a) is obtained. If the 
logs. of the picrotoxin doses are plotted against the 
corresponding evipan doses, a linear relationship 
is obtained, as seen in Fig. 23(b). The nature of 
these results agrees in general with those obtained 
by Maloney and co- workers (1931) and also by 
Koppanyi et al. (1936). 
Interpretation of the above findings: 
Evipan. The results of the experiments 
with continuous infusion of evipan alone have, as 
shown in a previous chapter, led to the assumption 
that about 1/25 to 1/30 of the evipan present is 
destroyed per minute. 
Picrotoxin. In case of picrotoxin a single 
dose of 0.3 mg. /kg. acts for about 20 minutes. 
The minimum effective dose was found to be 
(a) 0.2 mg. /kg. in the case of single injections 
and (b) 0.003 mg. /kg. /min. in the case of continuous 
infusions. 
A destruction rate of 1/70 per minute would 
account for this ratio. This corresponds to half 
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Fig. 23(a). Curve showing relation of the doses of 
continuous evipan and the antagonising doses of 
continuous picrotoxin. 
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Fig. 23(b). Curve showing the relation of the 
doses of continuous evipan and the logs. of the 
antagonising doses of picrotoxin. It may be noted 
that this practically a straight line. 
-107- 
of picrotoxin is thus about half that of evipan. 
Hence intravenous infusion produces relatively 
greater cumulation in the case of picrotoxin. 
Estimates of the rate of picrotoxin 
destruction made above vary from 1/48 to 1/87 
per minute. It would appear that between 1 to 2 
per cent. of the picrotoxin present is destroyed 
per minute. This rate is considerably slower than 
the rate found for evipan (3 to 5 per cent. removed 
per minute. 
In the case of evipan it was possible to 
produce fairly conclusive proof that a fixed 
proportion of the drug present was removed per 
minute. The evidence in the case of picrotoxin 
is less conclusive, but figures 17 to 20 show that 
with rates of infusion varying from 0.004 to 0.015 
mg. /kg. /min. it is possible to maintain a steady 
level of partial recovery of respiratory activity 
for hours. It is difficult to imagine how such a 
result could be attained unless a constant portion 
of the drug present is destroyed per minute, since 
only this mechanism will result in a constant 
intravenous infusion producing a steady effect. 
-108- 
Summary. 
1. Picrotoxin, as a respiratory analeptic, showed 
an increase in the amplitude as well as in the 
rate of respiration. Its action started at once 
but the maximum effect took some time to develop. 
Repetition of the same dose produced similar 
effects. 
2. Picrotoxin was steady in its effects at 
different depths of depression and produced a 
response even in extremely depressed conditions. 
3. A dose of 0.3 mg. /kg. of picrotoxin showed the 
same intensity of action as 10 mg. /kg. of cardiazol 
but picrotoxin had a longer duration. 
4. When a suitable dose of picrotoxin was 
continually infused simultaneously with a lethal 
dose of continuous evipan, the evipan was fully 
antagonised. The dose of evipan that could thus 





The analeptic activity of coramine was 
tested in the same manner as was described in the 
case of picrotoxin. A steady depression of 
respiration was produced in the rabbit by contin- 
uous intravenous infusion of evipan, and the 
stimulant action of coramine on respiration was 
estimated firstly by single injections and secondly 
by continuous infusion. 
I.(a) Effect of single doses of coramine. 
The result of an experiment of this group 
is shown in Fig. 24. The rabbit was receiving a 
continuous infusion of 0.5 mg. /kg. /min. of evipan 
following an initial dose of 15 mg. /kg. of evipan. 
When the depression was steady, a dose of 20 mg. /kg. 
of coramine was given. There was a prompt 
increase in the respiratory activity. This is 
shown by the quick rise in the respiratory curve; 
but the sharp descent of the curve indicated a 
rapid fall in the respiratory activity, and a 
short -lived action. The actual tracing showed 
an increase in the rate of the respiration rather 








Fig. 24. Respiratory curve of an experiment showing 
the intensity and duration of action of 20 mg. /kg. 
of coramine given to a rabbit udder continuous evipan 
0.5 mg. /kg. /min. following an initial dose of 15 mg./ 
kg. of evipan. 
-112- 
The durations of action of various doses 
of coramine as obtained in different experiments 
are given in a tabular form below. (Table VII) 
Table 'III. 
Dose of Log. of Durations in Average 
coramine the dose min. as ob- duration in 













22, 24 23 
28 28 
Plotting these doses with the average 
duration gives the curve shown in Fig. 25(a). If 
the logs. of these doses are plotter with the 
corresponding average duration, a straight line 
is obtained (Fig. 25(b). This indicates that the 
duration of coramine action varies with the log. 
dose of coramine. 


























































































































































































































































































































Extrapolation of the curves indicates that 
3 mg. /kg. would produce no action. The slope of 
the curve,when log. dose is plotted against time, 
corresponds to half destruction (decrease by log. 
0.3) in 8 minutes or a loss of 1 /10 per minute. 
A continuous infusion of 0.25 mg. /kg. /min. 
produced an appreciable effect. According to 
hypothesis already described, this should produce 
a maximum accumulation of 0.25 x 10 = 2.5 mg. /kg. 
This is just below the minimum effective dose that 
is calculated from Fig.25(b). 
It is of interest to note that the rate of 
destruction of coramine (1 /1C per minute) is much 
greater than that of picrotoxin (1/70 per minute). 
The analeptic action of coramine was found 
not to be constant in all cases. In some cases 
of extreme depression, especially when the 
depression was rapidly progressing, coramine 
failed to produce any change. An example of this 
can be seen in Fig. 26. In this case, 20 mg. /kg. 
of coramine, administered on a steady depression 
maintained by 0.5 mg. /kg. of evipan, produced a brisk 
response. But soon the respiratory activity began 
to decline very rapidly, as shown by the steep 
downward course of the curve. 
Fig. 26/ 
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On observing this, the continuous evipan was 
stopped and another 20 mg. /kg. of coramine was 
injected intravenously. In spite of this second 
dose, the downward course of the curve continued 
and the animal died in ten minutes. It seems 
that the rapid fall after the first injection 
might have been caused by some sort of hyper- 
sensitiveness of the animal to an intermediary 
breakdown product of coramine, but the point of 
special interest is the failure of the second 
dose to produce any effect whatsoever. A similar 
behaviour of coramine was observed in a few other 
experiments also. 
I. (b). Comparison with other analeptics. 
The respiratory curves of three experiments 
of this group are given in Figs. lE(a), 27 and 28. 
















































































































































































































































































































































































































In the first one, the depression was at the 50 
p.c. level, and the intensity of action of 10 
m.g /kg. of coramine was slightly more than that 
of 10 mg. /kg. of cardiazol or 0.3 mg. /kg. of 
picrotoxin, but the duration of the picrotoxin 
action was longer. In the second one, the 
depression was between 55 and 60 p.c. and the 
intensity of the action of 10 mg. /kg. coramine was 
equal to that of 10 mg. /kg. of cardiazol or of 
0.3 mg. /kg. of picrotoxin. In the third one, 
which had a depression level at about 80 p.c., 
even the effect of 20 mg. /kg. coramine was less 
than that of 10 mg. /kg. of cardiazol or of 0.3 
m.g /kg. of picrotoxin. In another experiment 
(Fig. 14(a) ) already reported, the depression 
line reached the 95 p.c. level, 30 mg. /kg. of 
coramine (in two doses within 5 minutes) failed 
to produce any effect whereas 0.3 mg. of picrotoxin 
started improving the animal's condition and 
another 0.4 mg. /kg. (given after 15 minutes) 
rapidly accelerated the progress and raised the 
respiratory curve to the 20 p.c. level in a 
quarter of an hour. Thus it was seen that in 
conditions/ 
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conditions of deeper depression coramine could 
not keep up the equiactive dosage relationship 
with cardiazol or picrotoxin and even failed to 
produce any effect in extremely depressed 
conditions. 
H. Continuous Infusion of Coramine. 
In this group of experiments, after 
obtaining a steady level of depression with a 
continuous infusion of evipan, coramine also was 
given by continuous infusion simultaneously. Below 
0.2 mg. /kg. of coramine per minute, no change could 
be seen in the horizontal course of the curve. A 
dose of 0.25 mg. /kg. per minute of continuous 
coramine caused a very slow rise of the curve as 
can be seen in Fig. 29, but after a while, in 
spite of the coramine continuing, the curve began 
to descend even below the evipan level. On stopping 
the coramine infusion, the curve slowly rose to the 
previous level of steady depression and then con- 
tinued a horizontal course. 

















































































































































































































































































































































































































A bigger dose (0.3 mg. /kg. /min.) of 
coramine infusion was again started and this 
produced a similar and more pronounced effect. 
After some rise, the curve began to descend and 
continued to do so till well below the starting 
level. On stopping coramine infusion, respiration 
improved till it reached the original evipan level 
which it followed as long as the evipan infusion 
was continued. still clearer was the picture 
presented in Fig. 30 giving results of a similar 
experiment. 
Fig. 30 / 
4 
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Fig. 30. Respiratory curve of another experiment 
showing the secondary depressant effect of continuous 
corainine infusion 0.3 mg./kg./min. 
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Discussion. 
This biphasic action of continuous coramine 
infusion leads to the assumption that coramine 
before final disposal in the body is changed into 
an intermediary product of a depressant nature 
which is dealt with less quickly than coramine 
itself and can therefore accumulate in sufficient 
quantity to more than neutralise the stimulant 
action of coramine. Further, the depressant 
activity of this intermediary product seems to be 
more pronounced at greater depth of original 
depression. This explains why at deeper levels 
of depression proportionately lesser effect is 
obtained from coramine. Cases of death after 
coramine (much below toxic doses) can be explained 
by individual hypersensitiveness of the animals 
to this intermediary product of coramine metabolism. 
This also explains the anomalous behaviour 
of coramine reported by some of the recent workers 
in the face of favourable reports of earlier 
literature. For example coramine in big doses 
was reported to have increased the depth or 
prolonged the duration of sleep caused by medanal 
(Tartler 1929), avertin (Jager, 1932; Lendle, 
1936), Zipf et al. (1937); pernocton (Lendle, 
1936/ 
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1936, Zipf et al. 1937), veronal, luminal and 
somnefene (Moritsh, 1932), and evipan (Schwab and 
Jung, 1936; Zipf et al. 1937) . 'rurther, , an 
increase of toxicity of the narcotic after coramine 
was reported by Moritsch (1932), Kohn and Jacobi 
(1935) 
(1935) and Zipf et al. (1937). Barlow /mentions 
a secondary depression following coramine and 
Maloney (1935) speaks of coramine as contra- 
indicated in deep barbiturate depression for, 
"beyond a stage it adds to the depression and kills 
by depression and not by convulsion ". Schwab and 
Jung (1936) suspected a "paralytic component of 
coramine". The results of the experiments with 
continuous coramine infusion suggest strongly 
that this suspected paralytic component is not 
present in coramine itself, but is, as suggested 
above, formed in the body in the shape of an 
intermediary product of coramine metabolism. The 
rapid breakdown of coramine may make it relatively 
safe or at any rate unlikely to cause convulsion. 
This advantage is, however, lost if coramine 




1. Coramine was found to have a quick but short - 
lived action as a respiratory analeptic. It 
improved the rate of the respiration rather than 
the depth. 
2. Its action was inconstant, and sometimes 
failed to respond. 
3. It could not maintain the same equi- active 
dosage relationship with cardiazol and picrotoxin 
at deeper levels of depression that it showed at 
a higher level. 
4. On a continuous infusion of coramine simul- 
taneously with 11. continuous evipan, the respiratory 
curve at first showed a slow rise and then a 
gradual fall even below the previous evipan level, 
to which it returned after stopping the coramine 
infusion. This suggested the formation of an 
intermediary product during coramine metabolism, 
which had a depressant action and was more stable 
than coramine itself. The anomalous behaviour 
of coramine also reported by other workers could 
be explained in this way. 
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VII. CARDIAZOL AND STRYCHNINE. 
-128- 
The effects of single intravenous injections 
of cardiazol on depressed respiratory activity 
maintained at a steady level by continuous slow 
infusion of evipan, can be seen in Figs.16(a), 27 
and 28. Cardiazol produced a prompt response 
like coramine but the improvement was more marked 
as regards rate than depth, although in this latter 
respect, it was somewhat better than coramine. 
Furthermore, the action of cardiazol was found to 
be more constant than that of coramine when there 
was great depression of respiration. Cardiazol 
(10 mg. /kg. ) increased respiratory activity to 
the same extent as did 0.3 mg. of picrotoxin in 
the experiment represented in Fig.160)where the 
depression was at the 50 p.c. line, although the 
picrotoxin effect lasted longer. This equi- 
active relationship was maintained in experiment 
shown in Fig. 27 where depression was at about 
60 p.c. as also in that shown in Fig. 28 where 
respiratory depression was at about 80 p.c. level. 
The duration of action of various doses of 
cardiazol as obtained in different experiments 
is given in tabular form below. (Table VIII). 
Dose/ 
Dose of 




5.0 mg. 0.69 









Duration in min. as 









24, 22, 24, 20 
31, 29, 32 
33, 35, 39 









Plotting these doses with the average 
durations gives the curve shown in Fig. 25(a). If 
the loss. of these doses are plotted with the 
corresponding average duration, practically a 
straight line is obtained (Fig. 25(b)) This 
indicates that the duration of cardiazol action 
varies/ 
-130- 
varies with the lo= dose of cardiazol. The slope 
of this log. dose -duration line corresponds to half 
destruction (= decrease by log. 0.3) in 10 minutes 
or a loss of 1/13 per minute. Similar calcul- 
ations with coramine showed a loss of 1 /10 every 
minute. 
The resuscitating power of cardiazol was 
seen in an experiment (Fig. 31) in which the 
respiration of a rabbit under continuous evipan 
(0.8 mg. /kg. /min.) stopped after 3 successive doses 
of 250 mg. /kg. of cyclamide (morpholine nicotinate). 
On administration of 50 mg. /kg. cardiazol together 
with artificial respiration, there was immediate 
resumption of respiratory activity which soon went 
up beyond 50 p.c. level. 
Fig. 32 gives the results of an experiment 
in which cardiazol was continuously infused. 
would be seen from the respiratory curve the 
improvement produced in respiratory activity could 
not be maintained by the drug although the subse- 
quent fall in effect was much less marked than 
in the case of coramine. 
Figs. 31 and 32/ 
25 
-131- 




, (.. C,, v` 





Fig. 31. Respiratory curve of an experiment in which 
basic depression was due to 0.8 mg. /kg. /min. of 
evipan after an initial dose of 18 mg. /kg. of evipan. 
After 20 mg. of coramine, 3 successive doses of 
cyclamide 250 mg. /kg. each, resulted in complete 
stoppage of respiration. Artificial respiration was 
started. 50 mg. /kg. of cardiazol at once caused 


























































































































































































On gradually increasing the dose of the amount 
infused, from 0.4 mg. /kg. to 0.5 mg. /kg. /min. this 
tendency became clearer and on continuing 0.5 mg. /kg. 
for some time twitchings and slight convulsive 
tendency appeared and then regular convulsions 
although respiratory activity was at about 40 p.c. 
level. 
Single injections of cardiazol at this level 
of depression do not give rise to convulsion unless 
the dose be big. It seems therefore that cardiazol 
also before destruction is converted into inter- 
mediary products, one of which is convulsive in 
nature. But besides this there has got to be some 
other factor which prevents continuous rise of 
respiratory activity and sometimes causes a 
diminution of the increased activity. In this 
respect it presents a more complicated picture 
than coramine. 
Strychnine after a single injection gave 
improved respiration. 0.1 mg. of strychnine gave 
less effect than 0.3 mg. of picrotoxin (Fig. '7) 
although toxicity of strychnine for rabbit was found 
by Maloney to be ten times that of picrotoxin. 
0.4 mg. /kg. of strychnine gave rise to severe 
convulsion/ 
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convulsion in an animal with 40 p.c. respiratory 
activity due to 0.75 mg. /min. continuous evipan. 
Fig. 33 gives the result of continuous injections 
of strychnine. 0.006 mg. very soon and 0.002 mg. 
after some time gave rise to convulsion although 
respiratory activity was increased only to a slight 
degree by that time. 
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Fig. 33. Respiratory curve of an experiment 
showing the effect of continuous infusion of 
strychnine. Convulsions appeared although 
respiratory activity was about 40 per cent. 
below normal. 
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VIII. CIRCULATORY EFFECTS OF IHE ANALEPTICS. 
-137- 
Earlier investigators stated that coramine 
was a stimulant to the circulation and that it 
acted on the myocardium and also produced vaso- 
constriction (Lagier, 1922; Faust, 1925; Asher, 
1926). Uhlmann (1924), however, reported that 
moderate doses of coramine had hardly any 
stimulant effect on normal blood pressure. Massart 
(1930) found that 25 mg. /kg. of coramine in dogs 
produced only a small rise of blood pressure. He 
further observed that after single massive doses 
of coramine there was,before the hypertensive 
response, a primary and transitory fall of blood 
pressure due to bradycardia of vagal origin. 
Killian and Uhlmann (1931) found this to be true 
for laboratory animals as well as for man. Van 
Esveld (1930) found that in decerebrate cats 
moderate doses of coramine had only a small effect 
on the blood pressure, while bigger doses caused 
convulsions. Stross (1928) found that in decapitated 
rabbits coramine failed to cause rise of blood 
pressure. Trendelenburg (1929) found that in 
vascular insufficiency and vasomotor paresis 
caused by novocaine, histamine and chloral hydrate, 
coramine/ 
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coramine failed to improve the blood pressure. 
Issekutz (1935) reported that coramine failed to 
combat the circulatory depression caused by 
chloroform in cats. 
Cardiazol has also been stated by various 
workers to cause a rise in blood pressure. Hilde- 
brandt (1925) reported that in urethanised cats 
2 to 14 mg. /kg. of cardiazol caused a moderate rise 
of blood pressure of fairly long duration. There 
was an initial fall of pressure if the vagi were 
intact. Plethysmographic experiments indicated a 
vasoconstriction in the splenchnic area with a 
compensatory dilatation of blood vessels in the 
skin and muscles. Camp (1928) was unable to 
find any definite or constant action of cardiazol 
on the heart. A concentration of even 1 in 1500 
did not produce any effect on the frog's heart. 
Contrary to Hildebrandt's findings, Camp showed 
by means of an oncometer, an increase of kidney 
volume after cardiazol. Goworow (1929) found 
that the ear vessels of the rabbit, when perfused 
with cardiazol, showed dilatation. Goworow and 




of cardiazol on the blood pressure of cats and dogs. 
They found that the cardiazol effect depended on 
the tonus of the autonomic as well as of the 
central nervous system. Cardiazol caused a rise of 
blood pressure only when the tonus of the vaso- 
constrictor centre was intact. In paralytic 
conditions of the central nervous system, the vaso- 
constrictor centre was one of the earliest to 
suffer and in such conditions, cardiazol caused 
central vasodilatation and a fall of blood pressure. 
The actior of these drugs on the circulation 
is a matter of practical importance, because 
coramine and cardiazol are both very extensively 
employed in clinical practice as circulatory 
stimulants. The author therefore made experiments 
to compare the circulatory effects of various 
analeptic drugs. 
In one experiment the blood pressure of a 
rabbit had fallen to about 15 mm. Hg in consequence 
of prolonged manipulation and exposure of the 
abdominal viscera, but neither 30 mg. /kg. of 
coramine nor 20 mg. /kg. of cardiazol produced any 
improvement. Observations on many cats showed 
that/ 
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that towards the end of lengthy experiments, 
when the blood pressure had fallen to a low level, 
these drugs often failed to produce any improve- 
ment. This confirmed Trendelenburg's (1929) 
finding as regards coramine and that of Gorowow 
and co- workers (1931) as regards cardiazol. 
It was found that vrith rabbits 10 mg. /kg. 
of coramine, 10 mg. /kg. of cardiazol and 0.3 mg. /kg. 
of picrotoxin were equi- active doses so far as 
respiratory analeptic activity was concerned. The 
vasomotor of these drugs in the doses 
were therefore compared in cats under chloralose 
anaesthesia. Both coramine and cardiazol had a 
prompt effect in causing a rise of blood pressure, 
but the effect was maintained by cardiazol for 
nearly twice as much time as coramine. As regards 
intensity of action also cardiazol was about 
twice as active as coramine. 
There was a marked difference between the 
effects of these drugs and that of picrotoxin. 
As in the case of its respiratory stimulant action, 
the circulatory effects of picrotoxin developed 
slowly but lasted longer (twice as long as the 
action of cardiazol). The extent of the rise of 
blood/ 
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blood pressure was nearly the same as that 
produced by cardiazol. 
In other experiments the behaviour of 
these drugs was studied on the lowered blood 
pressure caused by injection of evipan. A dose 
of 10 mg. /kg. of evipan was given to a cat under 
chloralose anaesthesia. A typical sharp fall 
of blood pressure and a slow rise back to normal 
was obtained (Fig. 34). Some time after, the 
same dose of evipan was again given, and when the 
maximum depression was produced, a dose of 15 mg./ 
kg. of corarrin_e was injected. This caused an 
improvement but did not fully counterbalance the 
evipan effect. Moreover the intensity of the 
coramine effect passed off quickly and so the 
evipan effect was manifest again. After an 
interval the same procedure was repeated with 
10 mg. /kg. of evipan and 10 mg. /kg. of cardiazol. 
The evipan effect was practically counterbalanced 
by the cardiazol, but the peak of cardiazol 
effect passed off quickly and the evipan depression 
re- appeared to some extent. After another inter- 
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10 n;. /kg. of evipan and 0.3 mg. /kg. of picrotoxin. 
Thera was a very slight effect on the blood 
prowaure curve in the beginning, but the blood 
pressure continued to rise steadily to slightly 
above the normal level, and this effect was 
sustained for more than 30 minutes. 
Discussion. 
Favourable reports about coramine and 
cardiazol as circulatory stimulants come mostly 
from clinical workers. But the majority of 
experimental evidence points to their questionable 
utility as circulatory stimulants in grave 
circulatory depression, especially when this 
accor- zanies or follows the depression of the 
central nervous system. The clinical evidence 
must be regarded as uncertain, because it is 
inpossihle to arrange controls in the case of 
drugs such as those under discussion which are 
used as erergency remedies. It seems probable 
that the favourable results of clinical work nave 
been die to the use of these drugs in cases where 
the/ 
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the vasomotor centre was not severely depressed. 
It has been seen that after barbiturates 
there is a fall of blood pressure. In the case 
of evipan this is due to vasodilatation of central 
as well as of peripheral origin and also to cardiac 
depression. Cases of barbiturate depression that 
call for the use of an analeptic are cases in 
which the respiratory centre has been severely 
depressed. Such a depression of the respiratory 
centre would be usually accompanied by circul- 
atory depression, caused by loss of tonus of the 
vasoconstrictor centre. Apart from whatever 
respiratory analeptic action coramine and 
cardiazol may exert in such cases, the circulatory 
depression is not likely to be combatted by them 
in absence of tonus of the vasomotor centre. 
Moreover their action is so short -lived that 
they cannot exert a prolonged beneficial effect 
on the circulation. ricrotoxir_ has a prolonged 
period of activity and would have proved a very 
useful agent against circulatory depression in 
such cases but unfortunately the action of this 
drug is slow to develop. The best way to combat 
such circulatory depression appears to be a 
combination/ 
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combination of a sympathomimetic drug and 
picrotoxin. The first will initiate the 
circulatory improvement and the second will keep 
up the improvement for a long time. 
Summary. 
1. In cases of severe vasomotor depression 
coramine and cardiazol fail to produce circulatory 
improvement. 
2. Coramine and cardiazol produce prompt 
circulatory improvement in cases where the de- 
pression is not severe. Cardiazol has a circul- 
atory action of longer duration than, and double 
the intensity of, a dose of coramine of equal 
respiratory analeptic value. 
3. Picrotoxin has a very long period of activity 
as a circulatory stimulant and the intensity of 
its action is nearly equal to that of cardiazol, 
but its action is very slow to develop. 
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IX. TESTING OF NE COMi-OUNDS FOR ANALErTIC 
EFFECTS. 
-14 ?- 
The method employed for the study of the 
analeptic effects of picrotoxin, coramine, cardiazol 
and strychnine, also proved to be a very efficient 
method for testing of new compounds for evidence 
of analeptic activity. The method (described 
it detail in a previous chapter) essentially con- 
sisted in the production of a steady condition of 
respiratory depression of a rabbit by a continuous 
infusion of sodium evipan (one mg. /kg. /rain. with a 
suitable initial dose). The drug to be tested 
was then injected intravenously in various doses and 
the effects of the drug on respiration could be 
read off from the respiratory curve. In cases 
where there was evidence of respiratory stimulation 
the effects produced were compared with those 
produced by a known analeptic ( coramine or picro- 
toxin), both in respect of the intensity of 
stimulation and the duration of action. A series 
of new compounds were tested in this way. The 
following description of the testing of cyclamide 
will serve as an illustration. 
Cyclamide/ 
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Cyclamide or morpholine nicotinate is a compound 
formed by adding morpholine radicle to nicotinic 
acid with elimination of H20. /2 C/ c o.o H -- H; N \ 













(nicotinic acid diethylamide ( COAL 
CH2 
Cyclamide was found to be much less toxic 
than coramine. Even 5 gram per kg. of cyclamide 
did not kill frogs, while frogs of the same batch 
and under similar conditions were killed by less 
than 1 gram per kg. of coramine. 300 mg. /kg. of 
coramine was found to be the median lethal dose 
for mice whereas even 2500 mg. /kg. of cyclamide 
did not cause death of any of the mice. 
The analeptic activity of cyclamide, 
however, was found to be very low. A dose of 
100/ 
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100 mg. /kg. of cyclamide produced less intense 
effect than 25 mg. /kg. of coramine although the 
duration of action was much longer. This low 
analeptic activity deprives cyclamide of its 
chance of being considered a useful respiratory 
analeptic in spite of the fact that its very low 
toxicity causes it to have a wide margin of safety. 
750 mg. /kg. of cyclamide, given intravenously to 
a rabbit, in 3 doses within a few minutes, caused 
severe respiratory depression. In this respect 
it behaved like coramine and nicotine, which in 
very big doses, may produce depression and death 
without causing convulsion. 
The other new compounds were also tested in 
the same way as cyclamide. Thirty compounds were 
tested; five of them proved to be respiratory 
depressants; five showed no appreciable action 
even with a dose of 100 mg. /kg.; and sixteen 
showed a very slight analeptic activity. Only 
four compounds showed moderate analeptic action 
and their activities varied from 20 p.c. to 75 
p.c. of that of coramine. They did not therefore 
possess any claim to come into the field of 





The continuous intravenous infusion of 
sodium evipan produces a respiratory depression 
that remains constant in its intensity for hours. 
The results indicate that a constant fraction 
(namely 1/25) of the evipan present in the body 
is destroyed per minute. 
The steady state of respiratory depression 
produced in the above way provides a very efficient 
method for the quantitative study of the analeptic 
activity of drugs. Single injections of analeptics 
superimposed on the continuous infusion of evipan 
give information about their intensity as well as 
the duration of their action. The former provides 
the basis for comparison of different analeptics 
and the latter gives data for calculating the rate 
of detoxication of the analeptics. The simultaneous 
continuous infusion of evipan and an analeptic also 
yields interesting results. For example, different 
doses of continuous evipan can be antagonised by 
suitable doses of continuous picrotoxin and these 
doses of evipan vary with the logarithm of the dose 
of picrotoxin required. 
The/ 
-152- 
The results of the study of the analeptic 
drugs dealt with in the foregoing chapters, show 
that picrotoxin is much more effective than either 
coramine or cardiazol in antagonising the depressant 
action of sodium evipan and are in general agreement 
with the findings of previous workers with respect 
to other barbiturates. This superiority of 
picrotoxin is shown most clearly in cases of great 
respiratory depression. ricrotoxin will produce 
a stimulant respiratory effect even after the 
respiration has been arrested by evipan, whereas 
coramine often fails to stimulate respiration when 
this is depressed to about one fifth of the normal. 
Moreover in such cases it may even augment the 
depression. Cardiazol is intermediate between 
picrotoxin and coramine. 
Experiments with continuous infusion of 
coramine simultaneously with continuous evipan 
have shown that coramine, after an initial period 
of stimulation, leads to depression which is greater 
than what would be due to evipan alone. This 
strongly suggests that coramine is broken down to 
form some more stable intermediary product which 
has a depressant action. The rapid breakdown of 
coramine/ 
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coramine may make it relatively safe or at any 
rate unlikely to cause convulsion. This advantage 
is however lost if coramine breakdown liberates 
some depressant agent. 
The chief properties of these analeptics are 

























Picrotoxin 0.2 0.8 4 30 
Coramine 3 60 20 6 
Cardiazol 3 45 15 8 
Picrotoxin has the most powerful action and 
the action is of relatively long duration. The 
obvious disadvantage of this drug is that there is a 
relatively narrow margin between the minimum 
effective and convulsive doses. This disadvantage 
is, however, lessened by the fact that barbiturates 
antagonise/ 
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antagonise the convulsive action of picrotoxin. 
The outstanding characteristics of coramine 
and cardiazol are that they have an action of 
short duration and a wide margin of safety, and 
their stimulant action is produced very rapidly.. 
The clinical popularity of these drugs is probably 
due to these properties. My experiments show clearly, 
however, that of the three drugs, picrotoxin alone 
is likely to be effective in severe respiratory 
failure produced by overdose of sodium evipan. 
The writer gratefully acknowledges his 
indebtedness to Professor A.J. Clark for his guidance 
and advice throughout the course of this work. 
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THE antagonism between barbiturates and analeptics has been inves- 
tigated in different ways by various authors. Maloney and co- workers 
[1931, 1932, 1933] gave graded doses of barbiturates to rabbits and 
followed these by varying doses of picrotoxin. They took the life- 
saving capacity of the latter drug as the chief measure of its analeptic 
efficiency. Koppanyi et al. [1936] produced hypnosis in rabbits by 
varying doses of nembutal, and measured the activity of picrotoxin 
by its power to cause awakening. This antagonism is presumably due 
to antagonistic actions of the drugs on the central nervous system. 
Another possibility is that analeptics increase the rate of detoxication 
of barbiturates. The latter explanation is improbable, and in the case 
of the antagonism of avertin by analeptics Beck and Lendle [1932] 
showed that in rabbits the rate of detoxication of avertin was not 
affected by analeptics given in doses sufficient to antagonise the 
hypnotic. 
The chief purpose for which analeptics are used clinically is the 
stimulation of the respiratory centre, and the most promising method 
of investigating the action of analeptics is to measure their effects on 
the respiratory centre after this has been depressed. The chief diffi- 
culty is to obtain a constant degree of depression of the respiratory 
centre. One method of producing this effect is to administer some 
drug such as phenobarbitone, which has a very prolonged action. 
The defensive mechanism of the body against drugs is, however, so 
complex and efficient that it is difficult to obtain a prolonged and 
uniform depression by such means. An alternative method is to give 
a continuous intravenous infusion of some drug which is quickly 
destroyed. 
The author showed [1939] that a steady state of respiratory depres- 
sion in rabbits can be produced and maintained for hours by giving an 
initial intravenous dose of 15 -20 mg. /kg. of sodium evipan and then 
maintaining a continuous intravenous infusion, at a rate of about 
1 mg. /kg. /min. of evipan. 
The uniformity of the infusion was ensured by the use of an apparatus 
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that maintained a steady flow of 0.1 c.c. per minute. Respiratory 
activity was recorded by Cushny's method [1913]. The animal was 
covered with a plethysmograph which was connected to a float recorder. 
The respiratory activity was measured by multiplying the frequency, 
and the amplitude of the respiratory movements recorded on the 
smoked drum by the writing -point of the recorder. The results were 
expressed as percentage of the normal respiration activity, and by 
plotting these values against time, curves of respiratory activity for 
the whole period of the experiment were obtained. 
A. PICROTOxIN. 
Two types of experiments were carried out : 
(1) Continuous intravenous evipan was given at a rate which pro. 
duced a steady respiratory depression. Single doses of picrotoxin were 
then injected and the amplitude and duration of the respiratory stimu- 
lation were measured. The same method was employed to compare 
the action of picrotoxin with those of other analeptics. 
(2) Measurements were made of the antagonism between a con- 
tinuous infusion of evipan and a continuous infusion of picrotoxin. 
This method permitted the balancing of evipan and picrotoxin, and it 
was possible to work up to a combination of doses of the two drugs, 
either of which alone would have been 
1. Antagonism of Evipan by Single Doses of Picrotoxin. 
When a rabbit whose respiration was maintained in a steady state 
of depression by a continuous infusion of evipan received a dose of 
0.3 mg. /kg. of picrotoxin, there was a temporary stimulation of respira- 
tion lasting for 20 -30 min. The improvement was both in respect of 
the depth of respiration as well as the rate, and it took about 5 min. to 
reach the height of improvement. The temporary nature of the effect 
indicates that picrotoxin is fairly rapidly detoxicated in the body. 
Since a dose of 0.2 mg. /kg. produced no certain stimulation of respira- 
tion, the result indicates that picrotoxin is reduced to 2/3 in about 
30 min. If the destruction follows an exponential course, then the 
loss corresponds to a destruction of about 1.4 per cent. per minute. 
A second dose of picrotoxin, given about an hour after the first, pro- 
duced an identical response, a fact which supports the view that the 
picrotoxin is completely detoxicated in the body in a fairly short time. 
When the effect of one dose had passed off, the respiratory depression 
reached the previous steady level on account of the continuous infusion 
of evipan, and a dose of the same or of another drug could now be 
given. By successive injections into the same rabbit, different ana- 
leptics were quantitatively compared under similar conditions. In 
general, 0.3 mg. of picrotoxin produced as much increase of respiratory 
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activity as did 10 mg. of coramine or 10 mg. of cardiazol, but the 
duration of action of picrotoxin was about double that of the latter 
drugs. Fig. 1 illustrates one such experiment. A remarkable feature 
Continuous in iision .5-m_94J win Evifian .. 
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Fia. 1.- Action of analeptics in antagonising respiratory depression produced 
by sodium evipan in rabbits. Ordinate: percentage of respiratory depression; 
abscissa: time in hours. 
of this figure is the steady basic level of respiratory depression which 
was maintained for 5 hours. 
2. Antagonism between Continuous Intravenous Infusion of 
Evipan and of Picrotoxin. 
In an experiment of this type, 0.6 mg. /kg. /min. of evipan, con- 
tinuously infused, maintained a steady depression of respiration for 
about an hour. Then 0.3 mg. /kg. of picrotoxin was administered, and 
it caused a partial recovery which was maintained at a constant level 
by a continuous infusion of 0.004 mg. /kg. of picrotoxin per minute. 
This result indicates that with this rate of infusion, the rate of destruc- 
tion of picrotoxin in the body nearly balanced the rate of infusion. 
This indicates a destruction of 0.004/0.3 or 1/75 per minute of the 
drug present. 
More striking results were obtained when infusions of evipan were 
given which would have caused respiratory arrest if not antagonised 
by picrotoxin. In one experiment 1.2 mg. /kg. /min. of continuous 
evipan (following an initial dose of 15 mg. /kg. of evipan) produced a 
progressively increasing depression, and a dose of 0.7 mg. /kg. of picro- 
toxin followed by 0.008 mg. /kg. /min. produced a steady level of partial 
recovery. This indicates a destruction per minute of 0.008/0.7 =1/87 
of the picrotoxin present. 
In another experiment, the partial recovery produced by 0.9 mg. /kg. 
of picrotoxin could not be maintained by 0.006 mg. /kg. /min. of picro- 
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toxin continuously infused. Hence the amount destroyed was more 
than 0.006/0.9 or 1/150 per minute. In another case of progressive 
depression caused by 2 mg. /kg. per min. of evipan, partial recovery 
caused by 0.7 mg. /kg. of picrotoxin could be maintained by 0.015 
mg. /kg. /min. of continuous picrotoxin. The figures suggest that there 
is a considerable individual variation, and that the amount of picro- 
toxin removed per minute varies between 1 and 2 per cent. of the 
amount present. 
The results obtained with continuous simultaneous infusion of 
picrotoxin and of evipan are summarised in Table I. If the logs. of 
picrotoxin doses are plotted against the corresponding evipan doses, 
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FIC. 2.- Relation between the rates of simultaneous infusion of sodium evipan 
and of picrotoxin which maintain steady respiratory depression in rabbits. Dose 
of sodium evipan plotted against log. of dose of picrotoxin. 
results agrees in general with those obtained by Maloney and co- workers 
[1931], and also by Koppanyi et al. [1936]. This relation explains why 
it is possible to antagonise a wide range of picrotoxin dosage by bar- 
biturates, whilst only a comparatively narrow range of barbiturate 
dosage can be antagonised by picrotoxin. 
Interpretation. -The results of the experiments with continuous 
infusion of evipan alone have, as reported in a previous communication 
[Das and Raventós, 1939], led to the assumption that in rabbits about 
1/25 (or 4 per cent.) of the evipan present is destroyed per minute. 
In the case of picrotoxin a single dose of 0.3 mg. /kg. acts for about 
20 minutes. The minimum effective dose was found to be (a) 0.2 
mg. /kg. in the case of single injections, and (b) 0.003 mg. /kg. /min. 
in the case of continuous infusions. A destruction rate of 1/70 per 
minute would account for this ratio. The estimates of the rate of 
picrotoxin destruction vary from 1/48 to 1/87 per minute, or between 
1 and 2 per cent. per minute of the picrotoxin present. This rate is 
considerably slower than the rate found for evipan (3 to 5 per cent. 
per minute). 
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TABLE I.- RESULTS OBTAINED WITH CONTINUOUS SIMULTANEOUS INFUSION 

















E = evipan. 
P = picrotoxin. 
0.6 0.004 2 Antagonised. 0.6 E 0.004 P 
1.2 0.008 2 Antagonised. 1.2 E 0.008 P 
1-5 0-006 i Picrotoxin too 




1.5 E 0-01 P 
2.0 0.015 II- Antagonised. 2.0 E 0.015 P 
2.5 0.03 4 Antagonised. 2.5 E 0.03 P 
In the case of evipan it was possible to produce fairly conclusive 
proof that a fixed proportion of the drug present was removed per 
minute. The evidence in the case of picrotoxin is less conclusive, 
but Table I. shows that it is possible to maintain a steady level of partial 
recovery of respiratory activity for hours, and it is difficult to imagine 
how such a result could be obtained unless a constant portion of the 
drug present is destroyed per minute, since only this mechanism will 
result in a constant intravenous infusion producing a steady effect. 
B. CORAMINE AND CARDIAZOL. 
Coramine was studied in the same manner as has been described 
in the case of picrotoxin. A steady depression of respiration was 
produced in the rabbit by continuous intravenous infusion of evipan, 
and the stimulant action of coramine on respiration was estimated 
firstly by single injections, and secondly by continuous infusion. 
1. (a) (i) Effect of Single Doses of Coramine. 
Coramine injected intravenously into rabbits whose respiration was 
in a steady state of depression on account of continuous evipan caused 
a prompt rise in respiratory activity, mostly due to an increase in the 
respiration rate rather than the amplitude of respiration. The quick 
rise was followed by a sharp fall of the respiratory activity. There was 
slight variation in the duration of action of the same dose in different 
cases. The average of the figures obtained in different experiments 
is given in Table II. 
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TABLE II. 
Dose per kg. of coramine in mg. 5 10 20 40 
Log. of the dose . . . 0.69 1.00 P30 1.60 




If the logs of these doses are plotted with the corresponding average 
duration a straight line is obtained (fig. 3 (CRM)). This indicates that 
a 
Lay Dose OB my /A9 I O 11 1.4 16 
16 
FIG. 3. -Log. dose -duration relation of action of cardiazol and of coramine on 
rabbit's respiration. 
the duration of coramine action varies with the log. dose of coramine. 
Extrapolation of the curves indicates that 3 mg. /kg. would produce no 
action. The slope of the curve, when log. dose is plotted against time, 
corresponds to half- destruction (decrease by log. 0.3) in about 7 minutes, 
or a loss of 1 /10 per minute. 
A continuous infusion of 0.25 mg. /kg. /min. produced an appreciable 
effect. This should produce a maximum accumulation of 2.5 mg./kg, 
This is just below the minimum effective dose. 
(ii) Single Doses of Cardiazol. 
Single doses of cardiazol gave a prompt response like coramine. 
The improvement was more marked as regards the rate than the depth 
of respiration, although in this latter respect cardiazol was somewhat 
better than coramine. The average duration of different doses of 
cardiazol computed from a number of experiments is given in Table III. 
The average duration is plotted with the log. of the corresponding dose 
in fig. 3 (curve CZL). As in the case of coramine, the log. dose- duration 
relationship is a straight line. The slope of this line indicates that 
a 
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difference of log. 0.3 ( =time of half- destruction) occurs in 11 minutes, 
which corresponds to a detoxication at the rate of 1/16 per minute of 
the amount present. 
TABLE III. -AVERAGE DURATION OF DIFFERENT DOSES OF CARDLAZOL 
COMPUTED FROM A NUMBER OF EXPERIMENTS. 
Dose in mg. per kg. 
of cardiazol. 
5 7.5 10 15 20 30 40 50 
Log. of the dose . 0.69 0.87 1.0 1.17 1.3 1.47 1-6 1.69 
Average duration in 
min. 
5 9 14 21 22.5 31 36 42 
(b) Comparison of Single -dose Effects of the Analeptics. 
As already stated in connection with picrotoxin, the intensity of 
action of 10 mg. of coramine was in general equal to that of 10 mg. 
of cardiazol or of 0.3 mg. of picrotoxin. But it was noticed that 
coramine did not always keep up this equiactive dosage relationship. 
This was especially so after severe depression had been produced by 
evipan. In one experiment, for example, where the basic level of 
depression due to evipan infusion was 80 per cent. below normal, the 
effect of even 20 mg. /kg. coramine was less than that of 10 mg. of 
cardiazol or of 0.3 mg. of picrotoxin. In another case where the 
respiratory depression was about 95 per cent., 30 mg. of coramine 
failed to produce any effect, whereas 0.3 mg. /kg. of picrotoxin produced 
an improvement, whilst 0.4 mg. /kg. of picrotoxin given shortly after- 
wards restored the respiration nearly to normal. In other instances 
also, where depression was rapidly increasing, large doses of coramine 
failed to stimulate, and in some cases actually caused depression. 
2. (i) Continuous Infusion of Coramine. 
In this group of experiments, after obtaining a steady level of 
depression with a continuous infusion of evipan, coramine was also 
simultaneously given by continuous infusion. With a dose of 0.2 
mg. /kg. of coramine per minute, no change was observed in the amount 
of respiratory activity. A dose of 0.25 mg. /kg. /min. caused a very slow 
increase in the respiratory activity, but on continuing the coramine 
infusion for some time it was noticed that not only the increased 
respiratory activity was not maintained, but there was a progressive 
decrease in the respiratory activity even below the basic level of evipan 
depression. Stopping the coramine at this stage, but continuing the 
evipan infusion, actually led to increased respiratory activity till the 
basic level of evipan depression was reached. With a continuous 
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infusion of 0.3 mg. /kg. /min. of coramine a still clearer picture was 
obtained. Fig. 4 illustrates the result of one such experiment. 
Evi %an Q. . my //119/ minale 
a. 7S z 
12 11-30 I pm 1.30 2 pm 230 3 
Fia. 4.- Effect of coramine on respiratory activity of rabbit when this is 
greatly depressed by sodium evipan. Ordinate: percentage of respiratory 
depression; abscissa: time in hours. 
(ii) Continuous Infusion of Cardiazol. 
With a continuous infusion of cardiazol superimposed on a con- 
tinuous infusion of evipan, no effect was produced with doses below 
0.35 mg. /kg. per minute of cardiazol. A dose of 0.4 mg. /kg. /min 
produced a small improvement with a subsequent fall in activity, 
though in this respect this was much less marked than coramine. On 
gradually increasing the dose from 0.4 to 0.5 mg. /kg. /min. the above 
tendency became clearer, and on continuing 0.5 mg. for some time, 
twitchings and slight convulsive tendency appeared and then regular 
convulsions came on, although the respiratory activity was in general 
about 35 per cent. below normal. Single injections of cardiazol at this 
level of respiratory depression do not give rise to convulsions unless the 
dose be fairly large. It may be that one component of the breakdown 
product of cardiazol can produce convulsions and at the same time 
counteracts the respiratory stimulant action of cardiazol, which there- 
fore cannot keep up the respiratory stimulation. A more complicated 
picture is presented here than in the case of coramine. 
DISCUSSION. 
My results confirm those obtained by previous workers, and show 
that picrotoxin is much more effective than either coramine or cardiazol 
in antagonising the depressant action of sodium evipan on the respiratory 
centre. This superiority is shown most clearly in cases of great respira- 
tory depression. Picrotoxin will produce a stimulant respiratory effect 
even after the respiration has been arrested by evipan, whereas coramine 
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often fails to stimulate respiration when this is depressed to about 
1/5 of the normal. Moreover, in such cases it may even augment the 
depression. Cardiazol is intermediate between picrotoxin and coramine. 
Continuous infusion with coramine superimposed on continuous 
infusion with sodium evipan usually produces an initial respiratory 
stimulation, but within about half an hour the stimulation passes off, 
and is followed by a depression which is greater than that produced by 
sodium evipan alone. This effect, together with the depressant effect 
produced by large doses of coramine, suggests that the coramine is 
broken down to form some more stable product which has a depres- 
sant action. This also explains the anomalous behaviour of coramine 
reported by some of the recent workers in the face of favourable reports 
of earlier literature. For example, coramine in large doses was reported 
to have increased the depth or prolonged the duration of sleep caused 
by medinal [Tartler, 1929], avertin [Jager, 1932; Lendle, 1936; Zief 
et al., 1937], pernocton [Lendle, 1936; Zief et al., 1937], veronal, 
luminal and somnefene [Moritsch, 1932], and evipan [Schwab and 
Jung, 1936; Zief et al., 1937]. Further, an increase of toxicity of the 
narcotic after coramine was reported by Moritsch [1932], Kohn and 
Jacobi [1935], and Zief et al. [1937]. Barlow [1935] mentioned a 
secondary depression following coramine, and Maloney [1935] reported 
that beyond a stage coramine added to depression and killed by depres- 
sion and not by convulsion. Schwab and Jung [1936] suspected a 
"paralytic component of coramine." The results of the experiments 
with continuous coramine infusion suggest strongly that this suspected 
paralytic component is not present in coramine itself but is, as suggested 
before, formed in the body as an intermediary product of coramine 
metabolism. The rapid breakdown of coramine may make it relatively 
safe, or at any rate unlikely to cause convulsions. This advantage is, 
however, lost if coramine breakdown liberates some depressant agent. 
The chief properties of the three analeptics studied are summarised 





















dose (in min.) 
Time 
in min. 
for half - 
destruction. 
Picrotoxin . 0.2 0.8 4 30 46 
Coramine . 
Cardiazol . 
3 60 20 6 10 
. 3 45 15 8 11 
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is of relatively long duration. The obvious disadvantage of this drug 
is that there is a relatively narrow margin between the minimum 
effective and convulsive doses. This disadvantage is, however, lessened 
by the fact that barbiturates antagonise the convulsive action of 
picrotoxin. 
The outstanding characteristics of coramine and cardiazol are that 
they have an action of short duration and a wide margin of safety, and 
their stimulant action is produced very rapidly. The clinical popularity 
of these drugs is probably due to these properties. My experiments 
show clearly, however, that of the three drugs, picrotoxin alone is likely 
to be effective in the case of severe respiratory failure produced by 
overdose of sodium evipan. 
It is important to note that these conclusions only apply to the 
antagonism of the depression produced by barbiturates. Results 
recorded in the literature show clearly that the relative efficiency of 
the drugs is different as regards other respiratory depressants, such 
as morphine. I have confirmed this conclusion in some preliminary 
experiments. 
SUMMARY. 
1. The production of a steady state of respiratory depression by 
continuous intravenous infusion of sodium evipan into rabbits affords 
a convenient method for measuring the efficiency of analeptic drugs 
and for comparing their relative activities. 
2. Picrotoxin causes an increase in the depth of respiratory move- 
ments as well as in the rate, whereas coramine and cardiazol improve 
the rate of respiration rather than the depth. 
3. 0.3 mg. of picrotoxin causes the same increase in amplitude of 
respiratory stimulation as does 10 mg. of coramine or of cardiazoL 
Picrotoxin takes about 3 -5 minutes to develop its maximum effect 
whilst the action of coramine or of cardiazol reaches its maximum very 
quickly. 
4. When the respiratory depression is severe, coramine often fails 
to produce a stimulant effect and may even augment the depression. 
Picrotoxin still produces a stimulant effect in such cases. 
5. Picrotoxin is detoxicated at the rate of 1/70 of the amount 
present per minute, whereas the rate of destruction of coramine is abolm 
1 /10 and of cardiazol 1/16 of the amount present per minute. 
6. Continuous intravenous infusion of picrotoxin simultaneous 
with continuous infusion of evipan permits the balancing of evipan mil 
picrotoxin, and it is possible to work up to doses of both drugs, eitb6 
of which alone would be fatal. There is a linear relation between nlle 
doses of evipan and the log. of the doses of picrotoxin which 'miaow 
each other. 
7. Continuous infusion of coramine superimposed on the continuous 
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infusion of evipan at first shows an increase in the respiratory activity, 
but after some time there is a gradual fall and the final depression may 
be greater than that produced by evipan alone. This suggests the 
formation of an intermediary product during coramine metabolism, 
which has a depressant action and is more stable than coramine. 
I gratefully acknowledge my indebtedness to Professor A. J. Clark 
for his advice and help throughout the course of my work. 
The expenses of this research were defrayed by a grant from the 
Moray Fund of Edinburgh University. 
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THE CLEARANCE OF SODIUM E VIPAN. By S. C. DAS and 
J. RAVENTÓS. From the Department of Pharmacology, Uni- 
versity of Edinburgh. 
(Received for publication 6th July 1939.) 
INTRODUCTION. 
THE continuous intravenous administration of sodium evipan is now 
being used for the production of anæsthesia, and the experiments 
described below were made in order to determine the probable safety 
of this method. Widmark [1920] studied the clearance of narcotic 
drugs, whilst Widmark and Tandberg [1924] analysed the laws governing 
their cumulation and provided a mathematical treatment of the 
subject. 
He also showed that two forms of drug clearance occurred: 
(1) Exponential clearance with which a fixed proportion of the 
drug was removed per unit of time. 
(2) Constant clearance with which a fixed quantity of drug was 
removed per unit of time. 
Most drugs are cleared by the former method, and, indeed, ethyl 
and methyl alcohol are the only two important drugs known to be 
cleared by the latter method. 
Widmark and Tandberg [1924] demonstrated that these two forms 
of clearance were of great practical importance as regards the cumula- 
tion produced by continuous or frequent administration, because in 
the first case cumulation rose to a maximum after which no further 
increase occurred, whereas in the second case there was no limit and 
cumulation could continue until death was produced. 
The simplest method of expressing these two effects is as follows :- 
In the first case if x units are given per minute and 1/y of the drug 
present is removed per minute, then cumulation will occur until the 
removal equals the intake, and this happens when the amount in the 
body is xy. This form of cumulation has been shown to occur with 
acetone, chloroform, and ether. In the second case if a units are given 
per minute and b units are removed per minute, then a b units cumu- 
late per minute and cumulation can continue until a lethal dose is 
present. Methyl alcohol [ Widmark and Bildsten, 1924] and ethyl 
alcohol [Olow, 1924] have been shown to cumulate in this manner. 
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It is evident that continuous intravenous injection of drugs cleared 
by the second method can never be safe, whereas it should be possible 
to administer with safety drugs that are cleared by the first method. 
Various authors have used the method of continuous intravenous 
infusion to determine the form of clearance of non- volatile anæsthetics. 
Lendle [1932] showed that avertin when thus given was cleared in an 
exponential manner. Weese [1936] found that long- continued intra- 
venous infusion of sodium evipan (0.5 mg. /kg. /min.) in rabbits produced 
a steady state of depression, and concluded that clearance was ex- 
ponential in character. Voigt [1938] found in rabbits that a steady 
narcosis was produced by an initial dose of 14 mg. /kg. sodium evipan 
followed by 0.8 mg./kg./min., and that partial recovery occurred when 
0.75 mg. /kg. /min. was injected. 
The clearance of drugs is partly dependent on their distribution in 
the body, and the evidence available indicates that barbiturates are 
distributed in a manner similar to that found by Widmark [ 1920] for 
acetone, namely, a uniform distribution throughout about 75 per cent. 
of the body volume. 
Sodium barbitone [Koppanyi, Murphy, and Krop, 1933 ; Brundage 
and Gruber, 1937] when injected intravenously in dogs is rapidly 
distributed throughout nearly the whole body ; about three -quarters 
of the dose injected leaves the blood in 1 or 2 minutes, and equilibrium 
established between the blood and the tissues in 30 to 60 min. 
Thereafter the drug is slowly removed by excretion. 
The fate of a labile substance such as sodium evipan is more difficult 
to establish, but Weese's [1937] analyses (intravenous injection into 
rabbits) show that the blood concentration falls to a level corresponding 
to a uniform distribution throughout the body in about 30 min. Hence 
the immediate fate of sodium evipan appears to be similar to that of 
sodium barbitone, namely, a rapid distribution throughout nearly the 
whole body. 
These measurements do not provide much information regarding 
the rate of destruction of sodium evipan, but they show that during the 
first half -hour after administration the blood concentration of sodium 
evipan is influenced by two factors, namely, distribution between 
blood and body tissues and destruction in the body. The relative 
importance of these factors can only be determined with certainty by 
chemical analysis. 
The object of the experiments in this paper was to determine 
whether the intensity and duration of the action of sodium evipan 
agreed with the hypothesis that the drug was cleared in an exponential 
manner. The term clearance of sodium evipan is used to imply reduc- 
tion in the amount of active drug, and we have not attempted to 
determine whether the drug is broken down or is merely deviated by 
fixation by tissues other than the brain. 
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CLEARANCE OF SODIUM EVIPAN BY THE RABBIT. 
This was estimated by measuring the intensity of depression of respiration produced by continuous intravenous injection of evipan, and also by the duration of depression produced by single doses. Methods. -The respiratory activity of rabbits was measured by Cushny's method [1913]. The animal was covered with a plethys- mograph which was connected to a tambour, and the respiratory activity was estimated by multiplying the frequency and amplitude of the respiratory excursions measured on the paper. The results were expressed as the percentage of the normal respiratory activity. The animals were only partly narcotised, since the corneal reflex only disappeared when the respiratory activity was reduced to less than half the normal. Hence it was important to avoid any disturbance of the animal by noise or movement. The maintenance of a constant body temperature was very important. A thermometer was kept inserted into the rectum and a constant body temperature was main- tained by an electric heater under the animal. After prolonged periods of respiratory depression there appeared to be a considerable accumula- tion of carbon dioxide, because when the narcotic was stopped the respiration often recovered to a higher level of activity than the normal. Hence the recovery curves are not very reliable. A considerable individual variation was observed in the response to drugs, and hence the estimations of the amount of action produced by drugs were subject to a considerable error. 
The intensity and duration of the effects produced by single doses of sodium evipan were determined, and also the effects of continuous intravenous infusion. The latter was provided by a slow -turning screw acting on the plunger of a 10 -c.c. record syringe. It was found undesirable to introduce fluid at a greater rate than 1 c.c. per 10 min. In many cases we used the clinical method of giving an initial massive dose and following this with a maintenance dose given by continuous infusion. 
In order to interpret the effects of continuous infusion it was necessary first to know the intensity of depression produced by single intravenous doses of sodium evipan. This relation is shown in Table I. 
TABLE I.- RELATION BETWEEN DOSAGE OF SODIUM EVIPAN AND INTENSITY OF DEPRESSION OF RABBIT'S RESPIRATION. 
Dosage, mg. /kg. intra- 
venous 5 10 15 20 30 50 
No. of observations . 3 10 18 9 5 6 
Per cent. depression 
of respiration 15 37 49 50 62 70 -100 
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EFFECT ON RABBIT'S RESPIRATION OF INITIAL DOSE FOLLOWED 
BY CONTINUOUS INJECTION. 
This method of estimating the rate of detoxication of narcotics was 
introduced by Beck and Lendle [1932], who studied avertin. 
The effects of 24 experiments of this type are summarised in 
Table II. These results are of a semi- quantitative nature because 
there was a wide individual variation in sensitivity. For example, 
the same treatment in two different animals produced 20 and 45 per 
cent. depressions respectively in the respiratory activity. It was, 
however, easy to determine whether in any animal the continuous 
infusion caused increase or decrease in the respiratory depression 
produced by the initial dose. 






























































Slow recovery, nearly com- 
plete at 2.75 hours. 
Initial period of recovery 
for 1 hour, then steady 
state; depression 34-45 
per cent. 
Fall during 1 hour to steady 
depression (average 30 
per cent.). 
Depression nearly con- 
stant. After 1.25 hours 
55 -65 per cent. de- 
pression. 
Partial recovery to steady 
state 30 -40 per cent. 
depression. 
Steady increase in de- 
pression. Depression 
after 1 hour 45-57 per 
cent. (average 50 per 
cent.) . In 3 experiments 
continued until respira- 
tory arrest threatened 
which occurred at 1.75, 
2.75, and 3.5 hours re- 
spectively. 
Rapid depression 90 per 
cent. at 1 hour. 
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Table II. shows that an initial dose of 20 mg. /kg. sodium evipan 
followed by slow intravenous infusion at the rate of 1 mg. /kg. /min. 
produced a nearly constant depression of respiration. This effect can 
be accounted for equally well by either of the following assumptions: - 
(a) The rate of clearance is 5 per cent. (1/20) per min. of the drug 
present in the body. 
(b) The rate of clearance is constant at 1 mg. /kg. /min., and does 
not alter when the amount in the body changes. 
If the second supposition were true then it would be impossible to 
produce a steady depression of respiration by any rate of infusion of 
sodium evipan other than 1 mg. /kg. /min. 
If 20 mg. /kg. were followed by 0.5 mg. /kg. /min. and 1 mg. /kg. /min. 
were removed, then the whole of the initial dose would be removed 
in 40 min. and the animal would recover. If 15 mg. /kg. were followed 
by 1.5 mg. /kg. /min. and 1 mg. /kg. /min. were removed, then in 60 min. 
about 45 mg. /kg. would have accumulated in the body, a dose which is 
sufficient to arrest respiration (cf. Table I.). 
Table II. shows that infusion of 0.5 mg. /kg. /min. results in a steady 
state of moderate respiratory depression, whilst infusion of 1.5 mg. /kg./ 
min. takes between 1 and 3 hours to produce threatened respiratory 
arrest. 
The experimental results therefore indicate that a constant pro- 
portion of the drug present in the body is cleared per unit of time, and 
indicate a clearance of about 1/25 of the drug present per min. The 
rate of cumulation was calculated on this assumption, by use of the 
method described by Clark and Raventós [1938]. Table III. shows the 
TABLE III. -CONTINUOUS INTRAVENOUS INJECTION IN RABBITS. 
a. b. c. 
Dosage. g Dose mg./kg. 
calculated to be 
present after 
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calculated and observed figures ; it will be seen that the calculations 
provide results which agree in most cases with the observed results. 
The following experiments were made to provide as conclusive a 
proof as possible of the nature of the clearance of sodium evipan. An 
experiment of the type shown in Table II. was first made on a rabbit. 
A large dose (50 mg. /kg.) of sodium evipan was injected cautiously so 
that respiratory depression just short of arrest was produced ; this was 
followed by continuous infusion of 1 mg. /kg. /min. With this treatment 
the animal recovered to a steady state of 30 per cent. depression. 
A second experiment was made on the same rabbit a few days later. 
In this case no initial dose was given, but only a continuous injection 
of 1 mg. /kg. /min. This caused a slow fall of respiratory activity to the 
same steady state that was finally reached in the previous experiment. 
These effects are shown in fig. 1. Three pairs of such experiments were 







I I I I 
100min. 50 
Fia. 1.- Action on rabbit's respiration of continuous intravenous infusion 
of sodium evipan. 
Ordinate: respiratory activity as per cent. of normal; abscissa: time. A, con- 
tinuous i.v.i. 1 mg. /kg. /min. for 90 min. B, initial dose 50 mg. /kg. given over 
2 min., followed by continuous i.v.i. 1 mg. /kg. /min. for 75 min. 
The rate of continuous injection was the same in both the experi- 
ments shown in fig. 1, and the approximation to the same final steady 
state cannot be explained by the removal of a constant quantity of drug 
per minute, whereas this result is to be expected if a constant proportion 
of the drug present is removed per minute. These experiments there- 
fore provide fairly conclusive proof that the proportion and not the 
amount of drug removed per minute is constant. 
It was found possible to increase the rate of continuous infusion of 
sodium evipan by giving at the same time a continuous infusion of 
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picrotoxin. The antagonism between these drugs has been frequently described. When single doses of the two drugs were given it was found that the doses that balanced each other showed a linear relation between the dose of sodium evipan and the log. dose of picrotoxin. The relation found was that an increase of 50 mg. /kg. in the dose of sodium evipan was antagonised by a fourfold increase in the dose of picrotoxin. By means of simultaneous infusion of solutions of sodium evipan and of picrotoxin it was found possible to perfuse relatively large quantities of sodium evipan. For example, in one experiment the following drugs were given. An initial dose of 10 mg. /kg. sodium evipan was followed by continuous infusion of 2 mg. /kg. /min. for 130 min. At 45 min. 0.7 mg. /kg. picrotoxin was given, and this was followed by intravenous infusion for 85 min. of 0.015 mg. /kg /min. At the end of the experiment there was 65 per cent. depression of respiration. The animal received in 130 min. a total of 270 mg. /kg. sodium evipan, and, if the destruction had been steady, at 1 mg. /kg. /min. there would have been a cumulation of 140 mg. /kg. This is nearly three times the lethal dose, and it is improbable that it could be antagon- ised by the amount of picrotoxin given. On the other hand, if the destruction is at the rate of 1/25 per min. the final cumulation would only be 50 mg. /kg., and there is no reason why this quantity should not be antagonised by picrotoxin. This striking antagonism of sodium evipan by picrotoxin therefore provides confirmatory evidence that a constant proportion of sodium evipan is cleared per min. Our results indicate a destruction of 1/20 to 1/25 of the drug present per min., whilst Voigt's [1938] results with rabbits, analysed in the same way, indicate a destruction of 1/16 to 1/18. Kohn -Richards and Grimes (who have kindly communicated to us their results prior to publication) have studied the clearance of sodium pentothal given intravenously to rabbits, and conclude that it is cleared in an exponential manner and that 1/25 of the drug present is cleared per min. Our results are therefore in satisfactory agreement with those obtained by other workers. 
DURATION OF ACTION OF SINGLE DOSES. 
If the depression of the rabbit's respiration by sodium evipan is dependent on the rate of clearance and if this proceeds in an exponential manner, then there should be a linear relation between duration and log. dose, and the slope of the curve should indicate the fraction of drug removed per minute. 
Table IV. shows the relation between dosage and duration of depres- sion. These results approximate to a linear relation between both dose and time and log. dosé and time. Hence they do not prove the character of the clearance, but if the relation between log. dose and time be accepted then this indicates a removal per min. of 1/22 of the 
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drug present. The rate of clearance that accounts for the dosage - 
duration relation found with single doses is therefore the same as that 
calculated from continuous intravenous injection. 
TABLE IV.- DURATION OF DEPRESSION OF RABBIT'S RESPIRATION 
BY INTRAVENOUS SODIUM EVIPAN 
Dose mg./kg. . . 10 15 20 30 
No. of observations. . . 7 13 10 4 
Median duration of depression of 
respiration (minutes) . 18 25 33 41 
CLEARANCE OF SODIUM EVIPAN BY MICE. 
It was found possible to maintain narcosis in mice by continuous 
injection into a tail vein; a tuberculin syringe was used, and the rate 
of flow of fluid was 0.02 c.c. per min. The mice were kept warmed by 
means of an electric light. 
Raventós [1938] measured the effects of intraperitoneal sodium 
evipan at 30° C. on large numbers of mice, and found the median 
hypnotic dose to be 40 mg. /kg. and the median lethal dose to be 255 
mg. /kg. It was found (Table V.) that with intravenous injection the 
median hypnotic dose was about 45 mg. /kg., whilst the median lethal 
dose was between 150 and 180 mg. /kg. The latter figure depends on 
the rate of injection, since death can be produced by as little as 
70 mg. /kg. when this is injected rapidly into a vein. The figures in 
Table V. were obtained when the injection was given cautiously over a 
period of about a minute. 
TABLE V.- ACTION OF SODIUM EVIPAN GIVEN INTRAVENOUSLY TO MICE. 














(in 2 min.). (2 -60 min.). Incidence. in min. 
250 4 4 .. 
200 (i 2 2 2 > 180 
180 6 2 2 2 > 120 
150 5 .. 1 3 90-120 . 
100 5 .. .. 5 20-30 
70 10 .. .. 8 10-15 2 
60 4 .. .. 2 5 2 
40 4 .. .. .. .. 4 
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TABLE VI.- EFFECT OF SODIUM EVIPAN GIVEN TO MICE BY CONTINUOUS INTRA- 
VENOUS INJECTION AFTER INITIAL INTRAVENOUS DOSE OF 70 MG. /KG. CONCEN- 





mice. Deaths. Effect. 
20 3 3 Average time of death 20 minutes. 
10 5 5 Average time of death 36 minutes. 
5 3 0 Increased depth of narcosis. 
3.5 3 0 ,, 2.5 3 0 Two cases increased depth narcosis. 
One case narcosis unchanged. 
2.0 5 0 Three cases narcosis unchanged. 
Two cases decreased depth narcosis. 
1.5 3 0 Decreased depth narcosis. 
1.0 2 0 I, If Pl 
Table VI. shows the effects of continuous intravenous injection. A 
rate of 2 mg. /kg. /min. maintained unaltered the anæsthesia produced 
by an initial dose of 70 mg./kg., and this indicates a loss of 2/70 =1/35 
per min of the drug present. If this fraction be accepted then injection 
of 5 mg. /kg. /min. should produce a maximum cumulation of 35 x 5 =175 
mg. /kg., and injection at this rate actually produced deep anæsthesia 
but not death. 
Injection of 10 mg. /kg. /min. should raise the initial dose of 70 mg. /kg. 
to 246 mg. /kg. in 35 min., and this rate of injection caused death in 
this time. Injection of 1.5 mg. /kg. /min. should result in a gradual 
lowering of the drug present from 70 mg./kg. to 53 mg. /kg., and a 
decrease in the depth of narcosis was observed with this rate of infusion. 
Large numbers of animals would be needed to establish accurately 
the rate of clearance, but the results show that the rate of clearance in 
mice is less than that found with rabbits (1/25 per min.) and that it 
is certainly more than 1/50 per min. The relation between dosage and 
duration of action ought also to indicate the rate of clearance of the 
drug. Fig. 2 shows averages obtained from the intraperitoneal injection 
of more than 300 mice. The durations observed with the intravenous 
injection of a few mice (Table V.) also are shown for comparison. 
The outstanding features of the duration of evipan narcosis in mice 
are the wide individual variation and the tendency for median durations 
to fluctuate from day to day. Hence it is very difficult to obtain reliable 
data. Fig. 2 suggests that the duration of narcosis is definitely shorter 
after intravenous than after intraperitoneal injection, and therefore 
the latter measurement must be affected both by the rate of absorption 
and the rate of clearance. The general slope of the dosage -duration 
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relation after intraperitoneal injection indicates, however, a loss of 
about 1 /100 per min., and this rate is only 1/3 of that calculated from 
the results of continuous intravenous infusion. Neither of these 
methods of estimation is conclusive, but the latter appears to be the 
more reliable. Hence it is necessary to conclude that the relation 
between dosage and the duration of narcosis does not give a reliable 
measure of the rate of clearance of the drug. 
0 50 100 
2.- Relation between dosage of sodium evipan and china ion of sleep of mice. 
Ordinate: log. dosage in mg. /kg.; abscissa: duration in min. Solid line: intra- 
peritoneal injection: median results from about 300 mice. Dotted line: intra- 
venous injection: results from a few mice. 
CLEARANCE OF SODIUM EVIPAN BY MONKEYS. 
Storm [1935 -36] measured the durations of anwsthesia produced 
by single doses (20 to 140 mg. /kg.) of intravenous sodium evipan in 
52 monkeys (Macacus). The durations ranged from 15 min. to 10 hours. 
The results approximate to a linear relation between dosage and dura- 
tion. Over a considerable range of dosage they also approximate to 
a linear relation between log. dose and duration, and the slope indicates 
a clearance of about 1/140 per min. This result suggests that the 
clearance in monkeys is very much slower than in rabbits. 
We measured the effect on three monkeys (Macacus rhesus) of an 
initial dose of sodium evipan followed by slow intravenous injection. 
A dose of 20 mg. /kg. sodium evipan was found to produce a short 
hypnosis (20 min.). We found in one animal that when 25 mg. /kg. 
was followed by 0.75 mg. /kg. /min. signs of partial recovery occurred, 
and that when the same initial dose was followed by 1.5 mg. /kg. /min. 
dangerous respiratory depression occurred after half an hour. These 
results indicate a destruction of between 1/17 and 1/33 per min. of the 
drug present. Other results indicated a destruction of less rather than 
more than 1/30 per min. The rate of clearance of evipan in the monkey 
appears, therefore, to be slightly less than that which occurs in the 
rabbit. The monkeys present the same difficulty as mice in that 
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slow intravenous injection indicates a rate of destruction very different 
from that indicated by the dosage- duration relation. 
DISCUSSION. 
The effects of continuous intravenous injection of sodium evipan 
on the rabbit provide fairly conclusive evidence that the drug is cleared 
in an exponential manner (i.e. clearance per minute of a constant 
proportion of the drug present). The dosage- duration relation found 
for the depression of the rabbit's respiration indicates the same rate of clearance as does the continuous intravenous injection (i.e. about 
1/25 per min.). Continuous intravenous injection indicates rates of clearance in mice of 1/35 per min., and in monkeys of 1/30 per min. 
The relations between dosage and duration of narcosis in mice and 
in monkeys indicate, however, rates of clearance respectively of 1 /110 
and 1/140 per min. This gross discrepancy in the results shown by the 
two methods may be due to a variety of causes, e.g. occurrence of relatively stable breakdown products of lower activity than evipan, 
delay in clearance of the drug from the C.N.S., etc. The problem can 
only be solved by chemical analysis, but our results show that the 
dosage- duration relation provides evidence of doubtful validity regarding 
the rate of clearance of evipan. This is unfortunate, because this 
method of estimation is much simpler than any alternative method. 
SUMMARY. 
1. The effects produced on the respiratory activity of the rabbit 
by continuous intravenous injection of sodium evipan can be explained 
on the assumption that about 1/25 of the amount present in the body 
is inactivated every minute. These results cannot be explained on 
the assumption that a constant quantity of sodium evipan is inactivated 
per minute. 
2. The relations between dosage and duration of respiratory depression 
in the rabbit indicate a clearance of about 1/22 per min. of the drug. 
3. The effects of continuous intravenous injection in mice and 
monkeys indicate respective rates of clearance of 1/35 and 1/30 per min. 
4. The dosage- duration of narcosis relations in mice and in monkeys 
indicates the much slower rates of clearance of 1 /110 and 1/140 per 
min. respectively. The reason for the discrepancy in the results shown 
by the two methods is not known. 
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